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ABSTRACT 
Due to their simplicity, viruses require the assistance of host factors for various aspects of their 
replication cycle. This study investigated the interaction of one of the two non-structural 
replicase proteins of rubella virus (RUBV), P150, with cell proteins. RUBV forms replication 
complexes for replicating its RNA in association with membranes of endosomes and lysosomes; 
the thusly modified endosomes/lysosomes are termed cytopathic vacuoles or CPVs. In the first 
study, a RUBV expressing a FLAG epitope-tagged P150 was used to co-immunoprecipitate 
putative interacting cell proteins from an infected cell lysate fraction enriched for CPVs using 
differential centrifugation.  However, the only interacting protein identified was the companion 
RUBV replicase protein P90.  Thus, cell proteins do not bind with either sufficient affinity or in 
stoichiometric amounts to be detected by this method and may not be a component of the virus 
holoenzyme.  In the second study, a proline-rich region within P150 with three PxxPxR 
consensus SH3 domain-binding motifs was investigated for its ability to bind cell proteins.  
Substitution mutations (to alanine) of the two prolines were made in each of these motifs with 
the finding that mutations in the first two motifs led to lower viral titers and a small plaque 
phenotype with reversion to the wt sequence within one passage.  Mutations in the third motif 
had a wt phenotype and did not revert.   However, these mutations did not affect viral RNA 
synthesis, suggesting that the importance of these motifs is in a later stage of viral life cycle, e.g. 
virion assembly and release. To extend these findings, the proline hinge region with either the wt 
or mutant sequence was expressed as a GST-fusion in human cells.  Pulldown experiments 
revealed specific binding with human p32 protein (gC1qR), which was previously shown to 
interact with the RUBV capsid protein.  Binding of p32 with P150 was confirmed.  The function 
of p32 in the RUBV replication cycle is unclear, but could involve virion assembly and release 
or induction of apoptosis.  
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CHAPTER 1 
Introduction 
History and clinical manifestations 
 Rubella, the disease, was first described in the 1700s by two German physicians, de 
Bergan in 1752 and Orlow in 1758, the reason behind the synonym for the disease “German 
measles” [1]. Rubella was initially not recognized as a separate disease entity; rather it was 
associated with both scarlet fever and measles until 1814, when it was finally recognized as a 
distinct disease and named “rothëln”. The physician who made this discovery was George de 
Maton and subsequently the disease was renamed rubella by the Englishman Henry Veale in 
1866, who described the original term, “rothëln”, as “foreign to the ears”  
 Rubella was thought to be a benign disease until an important discovery in 1941 by 
Norman Gregg, an Australian ophthalmologist. He found that there was a correlation between 
teratogenecity in newborn infants and contraction of RUBV by their mothers during pregnancy. 
Specifically, this hypothesis was based on case studies collected by himself and his colleagues 
showing a significant incidence of cataracts in babies born to mothers who were infected with 
the virus during their pregnancy. The clinical manifestations of congenital rubella were more 
extensive than the occurrence of cataracts. Some of the other manifestations that were 
recognized were cardiac defects, deafness, retarded development leading to low birth weight and 
microcephaly. 
 A rubella epidemic in the United States between 1964 and 1965, led to the recognition of 
a variety of other congenital rubella defects. Approximately 20,000 cases of congenital rubella 
syndrome (CRS) were recorded during those years and this vast number of CRS cases 
contributed to the recognition of a variety of other defects that occurred as a result of congenital 
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infection [2]. The occurrence of multiple defects was seen primarily when infection took place 
during the first eight weeks of pregnancy. The fetus is at risk for congenital defects for up to 
about twelve weeks of pregnancy and this includes an increased risk of death and stillbirths [3]. 
Some of the other complications associated with congenital rubella are purpura and 
thrombocytopenia, enlarged liver and spleen, bone defects and central nervous system damage. 
 In contrast, complications are rare in children and adults who are infected by the virus. 
The complications that do occur most usually involve arthritis and arthralgia, two forms of joint 
complications that primarily affect adult women [4]. It is believed that the virus persists in 
synovial cells and fluids of the joints.  The live attenuated vaccine virus causes transient arthritis 
in ~10% of adult female vaccinees.  Why and how arthritis occurs, and primarily in women, is a 
point of interest that has not been explored.  Acute rubella can also lead to a post-infectious 
encephalitis, which is rarely fatal [5].  As for the disease in infected children and adults, the 
incubation period varies between 14 and 22 days. The earliest sign of infection is 
lymphadenopathy [6] and, in some cases, fever. Rash appears after this incubation period and 
typically lasts for three days (leading to another synonym for the disease, “three day measles”). 
Rash usually starts on the face and spreads to the neck and trunk. Patients are a risk to naïve 
individuals for about a week after the onset of rash. Serum antibodies appear at the time of rash 
and virus can be isolated from nasopharyngeal washing from four to seven days after appearance 
of the rash [6].  The route of horizontal transmission is respiratory, whereas vertical transmission 
to the unborn fetus is due to a systemic infection of the mother, spreading through the placenta 
and establishing a chronic infection in the fetus. 
 Thus far, immunization before pregnancy is the only preventive measure to counter the 
occurrence of CRS. The successful development of rubella vaccines began when permissive cell 
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culture systems used to isolate the virus were established in 1962 [7]. Two groups independently 
identified cell lines that permitted the growth and isolation of rubella virus (RUBV); one was a 
primary African green monkey kidney cell line developed by the Parkman group (Walter Reed 
Army Institute of Research) and the other was a human amnion cell line developed by the Weller 
and Neva group (Harvard School of Tropical Health). However, Parkman’s group was the first to 
develop a live attenuated vaccine, HPV-77, in 1966 [8]. A derivative of vaccine (HPV-77/DE-5) 
was the first RUBV vaccine licensed for usage in the United States in 1969. It was later replaced 
with the RA27/3 vaccine strain when the vaccine program was expanded in 1979. 
Rubella virus (RUBV) and teratogenicity 
 The exact mechanism by which congenital RUBV infection leads to CRS is unknown and 
has been a point of contention. We do know that infection by the virus in the developing fetus is 
persistent, facilitated by the undeveloped fetal immune system at the time of infection.  Virus 
penetration in the developing fetus is widespread, affecting many organs; however, the 
percentage of infected cells in affected organs is low, on the order of 1 in 10,000 [9].  Necrotic 
lesions are detectable, but not widespread, and immunopathological damage is nonexistent.  The 
primary observation is aborted fetuses with small organs or tissues size due to a reduced number 
of cells.  
 As for the mechanisms that cause this pathology, there are several ideas stemming from 
observations made from a variety of studies involving the effect of RUBV on infected culture 
cells. Several studies have shown that cell lines infected by RUBV grow more slowly or stop 
growing altogether after a few passages. This has been attributed to mitotic inhibition and 
chromosomal breakage leading to disruptions in cell growth [10, 11] and/or the presence of an 
uncharacterized protein in the supernatant of infected cells [12]. Another study showed that 
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infection of Vero (African green monkey kidney) cells by RUBV led to the progressive 
disintegration of actin microfilaments [13] a finding that would lend support to mitotic inhibition 
as a possible mechanism for cell cycle disruption because actin microfilaments are the basis for 
the development of mitotic spindle.  
 Aside from the physical disruption of cell division, other studies pointed to the possible 
role of interaction of RUBV proteins with host cell proteins as a contributing factor to the 
occurrence of CRS. In particular, it was shown that one of the RUBV nonstructural replicase 
proteins, P90, interacts with two host proteins, retinoblastoma (pRB) [14] and Citron-k Kinase 
(CK) [15], which function in growth and differentiation and cell cycle regulation, respectively. 
Either RUBV infection or over-expression of P90 [15] led to cell cycle arrest and the presence of 
cells in the population exhibiting tetraploidy. Since it is known that the symptoms of CRS are 
associated with retardation of organ development and genetic damage, it was speculated that 
disruption of cell cycle by RUBV P90 may be a mechanism of the disruption of organogenesis. 
 A series of studies done by several different labs showed that RUBV induces apoptosis in 
a variety of cell lines, pointing to the possible role of apoptosis in organ underdevelopment. 
RUBV-induced apoptosis appears to be through both p53-dependent and independent pathways 
[16-20].   In one cell line, overexpression of the virus capsid protein promoted induction of 
apoptosis while in another cell line, overexpression of one of the replicase proteins, P150 
appeared to be the inducer.  Thus, the phenomenon of induction of apoptosis by RUBV is 
complicated and likely cell line dependent.  In this regard, Adamo and Zapata found that RUBV 
does not induce apoptosis in primary human embryo fibroblasts (undifferentiated and 
proliferating cells), but does so in human normal-term placenta chorionic villi explants [21]. The 
finding was confirmed in a follow up study that used a line of primary fetal fibroblasts in 
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comparison with a line of adult lung cells [22].  In this study, it was found that the adult cells 
were programmed for apoptosis while in the fetal cells apoptosis was supressed. This finding 
could potentially explain the persistence of RUBV in infected fetuses, but seems to rule out 
apoptosis as a mechanism for the pathogenesis of CRS.  
RUBV genomic coding strategy and replication cycle 
 RUBV virus is the sole member of the genus RUBV within the Family Togaviridae. The 
single-strand RNA viral genome is 9,762 nt in length and encodes two open reading frames 
(ORF’s) [23]. The genome has a 5’ cap structure [24], a 5’ open reading frame and a 3’ poly-A 
tail [5],  features that allow it to act as a messenger RNA when released into the host cell.  The 
genome is thus considered to be of “positive” or “plus-sense” polarity. The genome RNA also 
has 5’ and 3’ cis acting elements (CAE) which have been shown to be important for virus 
replication [25, 26]. A diagram of the RUBV replication cycle is shown in Fig. 1.1.  Upon entry 
of the virus into a host cell, which is thought to occur via receptor mediated endocytosis [27], 
cell-viral membrane fusion followed by release of the genome from the capsid occurs. Once 
released into the cytoplasm, the genome serves as an mRNA from which the ORF at its 5’ end is 
translated to produce the viral nonstructural protein (NSP) precursor, P200, that is cleaved to 
generate two mature nonstructural proteins (NSPs), P150 and P90. P150 and P90 are located at 
the N- and C-terminal ends of P200, respectively.  The protease that cleaves the P200 precursor 
lies at the C-terminus of P150.  This nonstructural (NS) protease is a cysteine protease, with 
residues Cys-1151 and His-1272 as the catalytic dyad [28, 29], that catalyzes the cleavage of 
P200 at a single site, between the Gly-1301 and Gly-1302 residues. The protease domain is the 
only domain within P150 whose function has been experimentally proven. The other domains 
within RUBV P150 are the methyl/guanylyltransferase domain, the proline rich or hypervariable 
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domain, and the X-domain, which shares homology with adenosylribose phosphatases (ADP-
ribose-1-phosphatase) of cells and other RNA viruses [30] (see Fig. 1.2 for non-structural protein 
predicted motifs). The P90 nonstrucural protein contains the virus helicase domain [31] and the 
RNA dependent RNA polymerase (RDRP) domain [32].  The helicase domain has been shown 
to have ATPase activity while mutagenesis of the catalytic GDD domain characteristic of 
RDRP’s abrogates infectivity.  
 In the infected cells, the plus strand genomic RNA serves a dual purpose. First, it serves 
as a messenger RNA as discussed above; and second, it serves as the template for the synthesis 
of a minus-strand genomic complement. The minus-strand RNA is the template from which 
more genomic RNA is synthesized (40S) and from which a subgenomic mRNA is transcribed. 
The subgenomic RNA contains sequences from the 3’ end of the genomic RNA, which encode 
the 3’ proximal ORF.  The RUBV structural proteins are translated from this subgenomic RNA 
to produce a p110 polyprotein containing the viral capsid and glycoproteins E2 and E1, in that 
order [24, 33]. During translation of the polyprotein, translocation into the ER occurs mediated 
via signal peptides present in the amino termini of E2 and E1, and cleavage ensues within the ER 
lumen to produce the mature structural proteins [34, 35]. Cleavage of the structural polyprotein 
is mediated cotranslationally by cellular signalase [35]  present in the lumen of ER, so that the 
p110 precursor is not observed in infected cell lysates. 
 P200 appears to catalyze synthesis of the minus strand RNA from the genomic RNA 
while P150 and P90 catalyze synthesis of the genomic and subgenomic plus strand RNAs [36].  
Thus, proteolytic cleavage controls RNA replication. RNA replication occurs in so-called 
replication complexes (RCs) contained in spherules that appear on the inner surface of 
endosomes and lysosomes in infected cells [37, 38] (see Fig. 1.3). These modified endosomes 
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and lysosomes in infected cells have been termed cytopathic vacuoles or CPVs. CPVs are 
approximately 0.6-2.0 µm in diameter and the membrane spherules that line the CPVs at regular 
intervals are 50 nm in diameter. The presence of active RCs in these spherules has been 
demonstrated using antibodies against double stranded RNA, an intermediate in the replication 
process, via immuno-electron microscopy [39, 40]. Biogenesis of CPVs leads to a redistribution 
of some of the organelles in the infected cell. Specifically, the RER, Golgi, and mitochondria are 
recruited to the area surrounding the CPV.  The subgenomic RNA is translated in association 
with the RER and the direct translation of this RNA following its synthesis is supported by the 
observation that thread-like ribonucleoproteins structures extend from the base of the CPV 
spherules and form connections with RER [41, 42]. Virion budding occurs into this Golgi and 
therefore the presence of Golgi at the location of viral genome synthesis would facilitate the 
packaging of mature virions in a compartmentalized region of the infected cell. The reason for 
the recruitment of mitochondria is less clear, although they could provide a localized supply of 
ATP.  
Virus and host protein interactions 
 Viruses require the assistance of host factors in general for various aspects of their 
replication cycles. This is because the simplicity of the viral genome does not allow for the 
coding of large numbers of complex proteins and as obligate intracellular parasites, viruses take 
advantage of what the cell has to offer. For example, RNA viruses that replicate in the cytoplasm 
and use viral encoded RNA dependent RNA polymerase (RdRp), have to modify the host 
cytoplasmic environment as normal eukaryotic RdRp functions occurs in the nucleus. As a 
result, host factors such as those involved in translation may be used as part of the viral 
replicative machinery. Examples of such interactions will be discussed later. 
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 There are different ways in which host cellular factors play a role in virus RNA 
replication. Some of these interactions will be described in more detail later. Host cellular factors 
have been shown to bind to both the viral genome as well as to the enzymatic replication 
complex to promote template recognition, template switching from translation to replication as 
well as promoting proper assembly of the replication complex. Intracellular membranes and the 
cytoskeleton also play important roles in helping to target virus proteins to the appropriate sites 
of replication and RNA replication of all plus-strand RNA viruses occurs in association with 
membranes [43-45]. Virus components could also interact with host cellular factors involved in 
signaling pathway. Some of these signaling pathways affect the cell cycle as well as the innate 
immune response of the host cell. Since our work is on RUBV, which is a positive sense RNA 
virus, some examples of host cellular factors interacting with other positive strand RNA viruses 
will be further discussed as some of these interactions might have functional parallels in RUBV 
infected cells. 
 The classic example of virus-host interaction is that of host proteins combining with the 
RDRP subunit of bacteriophage Qβ to comprise the complete enzyme complex [46]. Studies 
found that three host proteins EF-Tu, EF-Ts and ribosomal protein S1 were a part of the 
bacteriophage holoenzyme. These host components are part of the translation machinery of the 
cell. These host cellular factors function in the holoenzyme by conferring specificity to template 
binding. Studies involving bacteriophage Qβ replicase protein have shown that subunits S1, EF-
Tu and EF-Ts. enable template recognition of positive and negative strand RNA during the 
process of replication [47].  Additionally, a fourth host protein, HF1 (ribosome-associated 
protein) binds to the 3’ end of the genome to direct the synthesis of negative strand  RNA [48]. 
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This is a good example of how a virus uses host cellular factors to compensate for the lack of 
virus factors important for its replication. 
Subsequently, appropriation of host cellular factors involved in host cell translation has 
been found to be quite a common theme among different viruses. For example, the binding of 
eIF-3 (translation elongation factor 3) to both the RDRP and the 5’ and 3’ untranslated regions 
(UTRs) of the genomes of positive strand RNA viruses has been found to occur [49,50]. Studies 
done with brome mosaic virus (BMV) RDRP purified from infected barley cells [49] reported 
the copurification and enrichment of eIF-3. Addition of eIF-3 to BMV RdRp led to a 3-fold 
increase of minus strand RNA synthesis in vitro. eIF-3 has also been shown to associate with the 
RDRP complex of poliovirus (3AB-3CDpro) [50]. This interaction was hypothesized to be 
important for the binding of the replication complex to the 5’ cloverleaf of the genome in the 
replicative intermediate to facilitate the synthesis of genomic RNA from the minus strand 
template. In a study of host proteins binding to West Nile virus (WNV) RNA, it was found that 
the host translation factor eEF1α bound to the 3’ stem loop of the genomic RNA  [51]. 
Mutational analysis of this binding site caused a decrease in production of minus strand RNA, 
strongly pointing to the role of eEF1α in facilitating minus strand synthesis [52]. In another 
study involving the non-structural protein NS5A of bovine viral diarrhea virus (BVDV) that has 
a role in BVDV replication, interaction with translation elongation factor eEF1α was 
demonstrated [53]. This interaction was shown to be specific for BVDV NS5A protein and 
occurred consistently among the different BVDV isolates. This finding was relevant because the 
NS5A protein of BVDV is the most variable among the many BVDV isolates [54] and the 
conserved interaction of eEF1α with NS5A was highly indicative of the role of eEF1α in BVDV 
replication. 
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Techniques employed in investigating virus and host factor interactions  
 The preceeding discussion of some studies on the identification of host proteins involved 
in virus RNA replication reveals that three main techniques have been employed: isolation of 
pairing partners of expressed virus replicase proteins or domains of virus replicase proteins, use 
of viral RNA sequences as bait for binding of cell proteins in cell lysates, and isolation of 
replication complexes and replicase proteins from infected cells to identify cell proteins which 
co-purify. With the expansion of the sequence database, bioinformatics tools have been 
developed to predict specific interactions.  For example, the interaction of pRB and P90, 
described above [14], was originally predicted by bioinformatics algorithms using consensus 
sequences. Finally, gene deletion libraries in yeast and genome wide siRNA knockdown 
techniques have been employed to identify cell proteins essential for virus replication. 
Representative examples will be used to illustrate the use of each of these techniques, 
concentrating on studies that utilized RUBV or an alphavirus, the nearest relatives of RUBV. 
1) Detection of protein pairing partners through expression of proteins and/or protein 
domains.  The yeast two-hybrid system has been used extensively for the identification of 
protein pairing partners.  In this system, the protein of interest is expressed in yeast as a bait to 
identify pairing partners. The interaction of the bait protein with a binding partner (prey) 
expressed from a library leads to the transcription of a reporter gene downstream of an activating 
sequence resulting in colony selection and identification. In one such study, the interaction of 
RUBV capsid with the mitochondrial p32 protein was discovered [55].  RUBV capsid was used 
as bait to screen a CV1 (monkey cell) cDNA library and a strong interaction of capsid protein 
with p32 was found. The interaction of these two proteins were confirmed through co-
immunoprecipitation (both in-vitro and in-vivo) and immunofluorescence assays (IFA).  A 
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follow up of this work confirmed that p32 bound to RUBV capsid through two clusters of 
arginine present at the capsid’s N-terminus. Studies also showed that over-expression of capsid 
led to the clustering of mitochondria in the perinuclear region of cells. Mutations introduced in 
the p32 binding sites on capsid led to decreased mitochondrial clustering, implying that the p32-
capsid interaction is important for this phenomenon to occur. Virus induced mitochondrial 
clustering is a hallmark of RUBV infection [1] and this study suggested that p32 was directing 
the clustering of mitochondria to sites of virus production in association with capsid. The 
researchers also found that mutation of the p32 binding site on capsid led to a decrease in 
subgenomic RNA production, lower viral titers and altered plaque morphology.  The P90-citron 
K kinase interaction discussed above was also discovered by the yeast two hybrid system using 
P90 as bait [15]. 
 In another study done to identify binding partners of RUBV capsid, the  capsid protein 
was over-expressed as a GST fusion protein from a mammalian expression vector (pEBG 
expression vectors) [56]. The GST-capsid fusion protein expressed in transfected COS cells were 
isolated with its binding partners on gluthathione-agarose beads and high abundance cell 
proteins were identified by gel electrophoresis and mass-spectrometry analysis. Using this 
method, researchers identified poly (A)-binding protein (PABP) as a binding partner of capsid 
protein. This interaction once again was verified via both in-vitro and in-vivo methods.  PABP is 
a host protein that plays an important role in the regulation of translation [57]. The researchers 
postulated that the interaction of capsid protein and PABP may be important in the regulation of 
host translation by RUBV. By sequestering PABP, researchers hypothesized that translation 
would be inhibited and that this would favor the transition of viral genome from viral translation 
to packaging.  
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2). Identification of cell proteins interacting with viral RNA sequences.  This technique is 
based on the hypothesis that binding of host proteins to the cis-acting elements in viral RNA 
species facilitates specific binding of the viral RDRP to its template. Host proteins act as a 
bridge to recruit viral RNA to the RdRp and possibly are part of the enzymatically active 
ribonucleoprotein complex. In addition, host proteins that bind to different cis-acting elements 
(i.e at different ends of the same strand or on different strands) can regulate template switching. 
Using radiolabelled RNAs corresponding to cis-acting elements as probes, the binding of host 
proteins to 5’ and 3’ cis-acting elements of genomic and anti-genomic RNA have been detected 
and confirmed using gel mobility shift and UV crosslinking assays. Subsequently, using 
sequential chromatography or RNA affinity columns followed by mass spectrometry, host 
proteins that interact with specific RNA sequences can be identified. 
These techniques were used in the studies mentioned above that demonstrated that eEF-
1α binds to the 3’ cis-acting element of the West Nile virus (WNV) genomic RNA [51], similar 
techniques led to the identification of TIA-1 and TIAR binding to the 3’ stem loop of the WNV 
minus strand RNA [58, 59]. TIA-1 and TIAR are multifunctional RNA binding proteins that 
shuttle between the nucleus and cytoplasm and have roles in translation and RNA splicing. The 
effect of these host proteins on WNV replication was evaluated in TIAR and TIA-1 knockout 
murine embryo fibroblast cell lines. Results showed that WNV replication was impaired in the 
TIAR knockout cell line but not in the TIA-1 knockout cell line. Later studies showed that 
mutations of TIAR/TIA-1 binding sites made in the 3’ stem loop of the WNV minus strand in an 
infectious clone negatively affected plaque size, genomic RNA levels and virus production [60]. 
It was concluded that the binding of TIAR/TIA-1 to the 3’ stem loop of the WNV minus strand 
played an important role in the synthesis of genomic RNA and it was hypothesized that this 
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binding promoted RDRP specific recognition of the 3’ end of the minus strand template and also 
stabilization of the replication complex. The interaction of the 3’ stem loop of WNV minus 
strand RNA with TIAR/TIA-1, which are components of stress granules [61], was found to 
confer resistance to the formation of stress granules in infected cells. This study suggested that 
the interaction of the WNV negative strand 3’ stem loop with TIAR facilitated virus genome 
synthesis and inhibited the formation of stress granules, causing host translation machinery not 
to be shut down.   
In RUBV, several host proteins have been found to associate with stem-loops at the 5’ 
and 3’ ends of the genome strand. Calreticulin, a calcium binding protein was found to associate 
with a stem loop at the 3’ end of the genome RNA [62].  Only the phosphorylated form of 
calreticulin bound to the viral RNA.  However, a subsequent mutagenesis study failed to confirm 
that calreticulin binding to this stem-loop was important for replication [25]. In another study, 
the La autoantigen was found to interact with the 5’ stem loop of RUBV genome RNA [63]. La 
antigen is an RNA binding protein that is important for initiation and termination of RNA 
polymerase III [64] and is involved in autoimmune disease as a target of the immune system. 
The specificity of the RNA-protein interaction between the 5’ stem loop (+) of RUBV and the La 
autoantigen in samples that were positive for endogenous La antigen or recombinant La antigen 
together with the observed inhibition of this complex formation in serum containing anti-La 
antibody, demonstrated the functional relevance of this binding. Also, patients who were 
infected with RUBV had an increase in anti-La antibody. This increase is thought to be a 
contributing factor to the arthritis and arthralgia seen in adult female patients.  
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3). Isolation of host proteins binding to viral proteins in virus infected cells 
 Isolation of viral replicase proteins from infected cells by immunoprecipitation and 
identification of co-immunoprecipitating host proteins that interact with virus proteins of interest 
is an alternate technique. This approach has been used in three recent studies on interaction of 
host proteins with the replicase proteins of Sindbis virus (SINV), a member of the alphavirus 
genus. These studies used virus that expressed a GFP-tagged nonstructural replicase protein 
nsP3; the presence of this tag did not interfere with virus replication.  In one study, isolation was 
done following a time course from 2 to 10 hours post-infection and interacting host proteins over 
the time course were identified [65]. The control used for this experiment was free GFP that was 
expressed from a subgenomic RNA. Using this method, cellular redistribution that would occur 
as a result of virus infection was taken into account. Immunoaffinity purification from cell 
lysates was done with magnetic beads coated with polyclonal anti-GFP antibody and co-
purifying cell proteins were resolved by one dimensional SDS-PAGE and then identified by 
mass-spectrometry analysis. Once the identities of these proteins were determined, their 
interaction with nsP3 was confirmed using additional methods such as reciprocal co-
immunoprecipitation and co-localization.  Candidate interacting proteins were identified that 
interacted with nsP3 throughout the time course of infection (G3BP proteins) and as well as only 
during the late infection period (14-3-3 proteins). G3BP proteins have been shown to be 
involved in a variety of cellular processes including RNA metabolism, translation and assembly 
of stress granules. They also have a role in transport of RNA in and out of the nucleus [66-68]. 
Since SINV shuts down endogenous cell translation and redirects the translation machinery to 
the production of virus proteins, it was postulated that G3BP proteins may a play a role in the 
regulation of SINV translation possibly including sequestering host RNA in order to facilitate 
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virus translation. The 14-3-3- proteins consist of a group of proteins that are known 
phosphoserine-binding adapter proteins involved in cellular signaling. Since this interaction 
occurs later during virus infection, it was suggested that a phosphorylation event involved in host 
translation shutoff, shutoff of minus strand synthesis or other signaling cascades could be a 
functional result of this interaction.   
 Two additional studies were done to investigate host proteins that interacted with the 
nonstructural replicase proteins of Sindbis virus. In one of these studies, nsP3 protein tagged 
with GFP expressed from a Sindbis replicon (without structural proteins) was employed to study 
the localization of nsP3 and its association with host cell proteins [69]. In this study, the 
interaction of nsP3 with host proteins was studied in both mosquito cells (mosquitoes are vectors 
for this virus) and vertebrate cells (hosts that are acutely infected). Rather than 
immunoprecipitation as in the previously described study, control and nsP3-GFP expressing cells 
were homogenized and sedimented on sucrose gradients to fractionate cells components. 
Fractions containing different membranes were clearly separated and nsP3 was found in both 
nuclear and plasma membranes as well as in endosome-like vesicles suggesting multiple roles 
for nsP3: one function that is associated with replication complexes found in conjunction with 
the other non-structural proteins in the plasma as well as endosomal membranes, and another 
function that is possibly related to regulatory processes associated with its presence near the 
nuclei. Using this fractionation method, the researchers were also able to identify interactions 
between the G3BP1 and G3PB2 proteins, as well of other cell proteins (including two other 
stress reponse proteins, YBX1 and HSC70), with nsP3 by co-immunoprecipitation in both the 
membrane and nuclear fractions. The researchers were also able to identify the presence of 
dsRNA in the membrane associated fraction using Western blot analysis, indicating that 
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replication occurred in association with membranous structures as previously reported. In 
mosquito cells, Rasputin, an insect homolog of G3BP protein, interacted with nsP3 associated 
with a membrane fraction (endosome, microsome and plasma membrane). This finding indicated 
the conserved nature of this interaction in both vertebrate and invertebrate cells. 
 In the third study on the interaction of host cell proteins with the SINV replication 
complex, differential expression of proteins in cytoplasmic membrane fractions of infected and 
uninfected cells was compared [70]. Two-dimensional difference in-gel electrophoretic (2D-
DIGE) analysis was performed using Cy3 and Cy5 labelled proteins from membrane fractions of 
infected and uninfected cells. This study led to the identification of the heterogenous nuclear 
ribonuclear protein K (hnRNP K) as a cell protein enriched in cyoplasmic membrane fractions 
from infected cells. It was subsequently shown that hnRNP K co-immunoprecipitated with the 
SINV nonstructural proteins and the subgenomic (but not the genomic) RNA and it was 
hypothesized that it was part of the RC and played a role as in regulating the ratio of genomic 
and subgenomic RNA synthesis and subsequent subgenomic RNA translation.  While this 
method was a good method for identifying host proteins that were enriched in certain cellular 
fractions during infection, it was not a good way to identify interacting proteins that did not 
change in abundance at a specific location as a result of infection. 
4). Genomic scans.  A cell genome wide mutation approach to identify host genes involved in 
virus replication was done in yeast cells which were found to accommodate the replication of 
brome mosaic virus (BMV), a plant virus. In this study, using a single-gene deletion mutant 
library, the effects of many host proteins on BMV replication were rapidly analyzed [71]. It was 
found that the absence of approximately 100 genes either inhibited or stimulated BMV RNA 
replication and gene expression by 3 to more than 25 fold. One observation worth noting was 
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that deletion of the gene encoding an acyl-CoA binding factor involved in membrane 
sphingolipid biosynthesis inhibited BMV replication by 25 fold. Such an observation gives 
validation to the data because of the importance of cellular membranes as virus replication 
complex formation sites.  While fibroblast lines from mouse knock out lines can be used for the 
same end, recently siRNA knockdown libraries have been used to identify genes important in 
virus replication in commonly used cell culture lines.  For example, an siRNA screen was used 
to identify 305 genes in human cells that affect WNV replication [72].  Although this strategy is 
powerful, it identifies genes that function in any aspect of the virus life cycle, including some 
with epistatic rather than direct effects. 
Goals of the dissertation 
 The focus of my dissertation research was to continue the research on virus-host 
interactions in RUBV-infected cells, specifically interactions that involve binding of host factors 
to the RUBV P150 non-structural replicase protein, a protein that had not previously been 
investigated in this regard.  
Specific Aim 1. To identify host cell proteins interacting with P150 in RUBV-infected cells 
by co-immunprecipitation. 
Recently, a RUBV infectious clone expressing a P150 tagged with epitopes such as FLAG, HA, 
or c-myc became available in our lab allowing us to use commercially available reagents to 
immunoprecipitate tagged P150 from infected cells and to co-immunoprecipitate interacting 
cellular proteins. Therefore, the initial goal of this Specific Aim was to identify co-
immunoprecipitating cell proteins with the subsequent goal of characterizing their role in RUBV 
replication.  
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Specific Aim 2. To determine if the binding of cell proteins with the P150 proline rich 
region plays a role in virus replication.   
A proline rich region was previously identified in the P150 non-structural replicase protein that 
extends from residues 716 to 782 (out of 1301 amino acids). Proline rich domains in cell proteins 
often function as adaptor regions that mediate protein-protein association and are often involved 
in interactions between intermediates in cellular signaling cascades.  Commonly, these 
interactions are via SH3 domains and the P150 proline rich region contains three putative Class 
II SH3 binding motifs with the consensus sequence PxxPxR. To test the hypothesis that protein-
protein interactions mediated by these motifs were important during virus infection, mutations to 
disrupt putative binding were introducted into a RUBV infectious cDNA clone to see if a change 
in phenotype resulted and to characterize that phenotype.   
Specific Aim 3. To investigate the cell proteins bound by the P150 proline rich region. 
The P150 proline rich region was expressed as a GST fusion protein and used to specifically 
isolate interacting cell proteins in transfected 293-T human kidney cells.  Mutations predicted to 
interrupt the interactions mediated by the PxxPxR motifs were introduced into the fusion protein 
to ascertain the specificity of the interaction.  Proteins which specifically bound to wt P150 and 
not the mutant were to be identified by mass spec, their interaction with P150 confirmed and 
their importance in virus replication to be analyzed.   
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Figure 1.1. Schematic of RUBV virus life cycle. 
RUBV virus enters its host via receptor mediated endocytosis. Upon entry into the host cell, 
diassembly of capsid occurs, releasing the plus strand RNA genome into the cytoplasm. The 
viral plus strand genome acts as an mRNA, which then is translated to produce the virus non-
structural polyprotein (NSP). The NSP is processed by the viral protease to produce separate 
proteins referred to as P150 and P90 (RNA dependent RNA polymerase). Together, the proteins 
P150 and P90 form a replication complex that goes on to synthesize the minus strand RNA 
intermediate and more plus strand RNA. Following transcription at the sub-genomic promoter of 
the minus strand RNA, structural proteins (SP) are produced. SP is then processed by cellular 
proteases to form the mature structural proteins, capsid protein, and glycoproteins E2 and E1. 
These proteins function in packaging the plus strand genome to produce mature RUBV virus 
particles. 
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Figure 1.2. Motifs within RUBV P150 and P90 nonstructural proteins. 
Various domains present within the P150 nonstructural protein (1301 aa) are: MT 
(methyltransferase), aa 63-132; HVR (hypervariable region), aa 693-799; XD (X domain/ADP 
phophatase like motif), aa 817-985 and NP (nonstructural protease), aa 1000-1299. Domains 
present within the P90 nonstructural protein (aa 1302-2116) are: HEL (helicase), aa 1334-1585; 
RdRp (RNA dependent RNA polymerase), aa 1595-2115. 
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Figure 1.3. Presence of cytopathic vacuoles (CPV) in RUBV infected cells. 
Cells infected by RUBV appear to have modified endosomes and lysosomes termed cytopathic 
vacuoles or CPV. CPVs are 0.6 to 2 µm in size and form 50 nm spherules that line the vacuole 
membranes at regular intervals. The above images are from a review published by Risco et. al. 
[44]. The arrows indicate the presence of spherules within CPVs. The CPVs are often 
surrounded by cisternae of rough endoplasmic reticulum (RER) and mitochondria (mi).  
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CHAPTER 2 
Specific aim 1: Investigating the interaction of host cellular factors with RUBV non-
structural replicase protein P150 
Introduction 
 Positive strand RNA viruses have long been known to form RNA replication complexes 
(RCs) in association with intracellular membranes in the host cell, a subject that has  been 
extensively reviewed [1, 2]. These so-called “virus factories” are formed in association with 
various intracellular membranes. The viral factories for different virus families are associated 
with different intracellular membranes. Viruses from the Family Flaviviridae, such as hepatitis C 
virus (HCV) and yellow fever virus (YFV), form RCs that are contiguous with or derived from 
the rough endoplasic reticulum (RER) and Golgi apparatus [2, 4], while viruses from the Family 
Togaviridae, such as RUBV and Sindbis virus (SINV), form RCs within so-called cytopathic 
vacuoles (CPVs) that are modifications of late endosomes and lysosomes [2, 5-7]. The 
association of the RC with an intracellular membranous structure has been suggested to be 
important for the following reasons. Firstly, intracellular membranes provide a surface for the 
anchoring of RC. The anchoring of RCs to membranes is usually achieved by the attachment of 
the RC to the membrane through hydrophobic domains of virus replicase proteins. This 
mechanism has been shown for the non-structural protein nsP1 of Semliki Forest virus (SFV), a 
togavirus that was found to anchor the viral RCs to membranes of endocytic organelles via its 
hydrophobic domain [8]. The assembly and anchoring of the RC to membrane structures can be 
directed by host factors. As an example, it was found that replication of brome mosaic virus 
(BMV) was blocked when mutation of the yeast gene YDJ1 was made [10]. YDJ1 was shown to 
be important in early steps in the BMV virus replication cycle which included targeting of virus 
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non-structural proteins to the membrane and stabilization of RC. Another piece of evidence 
showing the importance of host membranes in establishing RCs was obtained in a study that 
involved mutations of the OLE1 gene in yeast cells that harbour brome mosaic virus (BMV) 
[11]. OLE1 encodes ∆9 fatty acid desaturase and is important for the formation of membranous 
structures. Mutation of this gene in BMV infected yeast cells affected early viral replication 
steps preceding the synthesis of virus negative strand RNA. From these finding, it is quite 
evident that intracellular membranes do play a viral role in the formation of viral factories 
containing RCs. 
 Formation of RCs that are located on and even enclosed within membranous structures of 
host cells are also important in creating a “safe haven” for the replicating RNA virus as the 
double stranded RNA (dsRNA) intermediates is targets of the host innate immune response [12]. 
dsRNAs produced as viral replication intermediates are recognized by different host pattern-
recognizition receptors (PRRs) [13]. These PRRs recognize conserved molecular motifs called 
“pathogen-associated molecular patterns” or PAMPs. Two classes of PRRs play a role in 
recognition of viral dsRNA intermediates, a class of RNA helicases including RIG-I and MDA-
5, and a Toll-like receptor (TLR), namely TLR3 [13]. Both of these classes of PRR induce type 1 
interferon responses (through different pathways) and pro-inflammatory cytokines that counter 
virus infection of both the cell and organism. However, the helicases function by recognizing 
intracellular dsRNA, while TLR3 primarily recognizes exogenous dsRNA. 
 Although numerous studies have been done that show the association of virus RCs with 
intracellular membranes, the exact mechanism of targeting and morphogenesis of RCs is mostly 
unknown. Not much is known either about the host factors that are physically present in active 
RCs simply because the isolation of such membrane bound complexes while preserving their 
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enzymatic integrity is difficult to accomplish. In this study, co-immunoprecipitation with tagged 
RUBV nonstructural replicase protein P150 was employed to identify host proteins interacting 
with this protein.  At first, P150 was immunoprecipitated from a post-nuclear supernatant 
prepared from lysates of RUBV-infected cells.  Subsequently, immunoprecipitation was done 
from a cell fraction enriched for cytoplasmic organelles (including the endosome and lysosome-
derived CPVs) by differential centrifugation [14].  While this modification was initially made to 
decrease background, we felt it was also more promising for identifying cell proteins directly 
associated with RCs.  This is the first study of host proteins associated with RUBV nonstructural 
proteins that was done. These studies were performed in RUBV infected cells. 
Materials and methods 
Cells and virus 
 Vero cells, a continuous line of African green monkey kidney cells obtained from the 
American Type Culture Collection, were grown and maintained at 35oC in a humidified 
atmosphere with 5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM) containing 5% fetal 
bovine serum (FBS) and gentamicin (10 µg/ml).  For infection, Vero cell cultures at ~80% 
confluence were infected at a multiplicity of infection (MOI) of 1 plaque forming unit (pfu)/cell 
with RUBV derived from the Robo502 infectious cDNA clone (Robo502 virus)[15] as control or 
Robo502-912 virus, which bears a FLAG-epitope tagged P150, derived from the Robo502-912 
infectious cDNA clone (Wen-Pin Tzeng, unpublished data). 
Preparation of virus infected cell lysates and immunoprecipitation 
 Ten 100 mm culture plates of Vero cells that had been infected with Robo502 or 
Robo502-912 virus for 48 hours were washed twice with ice-cold phosphate buffered saline 
(PBS) and the cells were lysed with modified RIPA buffer [10 mM Tris-HCl pH 7.4, 100 mM 
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NaCl, 1 mM EDTA, 1 mM EGTA, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100 and 
1X broad range protease inhibitor (ROCHE)]. The cells in the lysis buffer were incubated on ice 
for 20 minutes before centrifugation at 12,000 rpm (Beckman coulter, JA 20 rotor) for 5 minutes 
to remove nuclei and cellular debris. Ten ml of clarified lysate were incubated with 1 ml of 
prewashed (PBS + 0.1% Triton X-100) anti-FLAG monoclonal antibody-conjugated agarose 
beads (SIGMA) for 2 hours at 40C. The bound beads were washed three times with lysis buffer. 
and were eluted with 2 ml of a 100 µg/ml solution of FLAG peptide (SIGMA) and the eluted 
proteins were precipitated by addition of three volumes of ice cold acetone and incubation at -
20oC for 1 hour [16]. Precipitated proteins were collected by centrifugation at 12,000 rpm 
(Beckman coulter, JA 20 rotor), the acetone was removed, and the precipitated protein pellet was 
allowed to air dry for ~10 minutes. Precipitated proteins were resuspended in 250 µl of 2D 
rehydration buffer (7M urea, 2M thiourea, 4% CHAPS, 2% Pharmalyte [broad range pH 3-10] 
and 40mM dithiothreitol; the latter two components were added to the rehydration buffer just 
before use) and incubated at 30oC for 1 hour. An aliquot was subjected to SDS-polyacrylamide 
electorphoresis (SDS-PAGE), transferred onto nitrocellulose membrane (Whatman) using 1X 
transfer buffer (100 ml 10X transfer buffer [250 mM Tris, 1.92M glycine], 200 ml 100% 
methanol, and 700 ml deionized water) at 100V for 1 hour in a mini-Protean II apparatus 
(Biorad) and the Western blot probed with anti-FLAG antibodies (Sigma Aldrich) to confirm the 
presence of FLAG-tagged P150 in the sample.  
First dimensional isoelectric focusing (IEF) 
A 250 µl aliquot of resuspended immunoprecipitated proteins was applied to a 13 cm 
Immobiline strip (GE-Healthcare Life Sciences) with a nonlinear pH range of 3-10. The strip 
was covered with 1 ml of Dry Strip cover fluid (GE-Healthcare Life Sciences) and isoelectric 
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focusing was done using an IPGphor apparatus (Amersham) as follows:  Rehydration for 16 
hours at 30V; Increase to 200 V and hold for 1 hour; Increase to 500 V and hold for 1 hour; 
Increase to 1000 V and hold for 1 hour; Gradient for 30 minutes to 8000V; and Gradient for 
32,000 V/hr up to 8000V.  After isoelectric focusing, the strips were prepared for second 
dimension separation by SDS-PAGE. 
Second dimensional SDS-PAGE and protein spot isolation 
The IEF strips were removed from the IPGphor and washed for 15 minutes each with 10 
ml of 1% DTT and 10 ml of 4% iodoacetamide. The strips were then transferred to the top of a 
10% SDS-PAGE gel (10% acrylamide, 0.38 M Tris pH 8.8, 0.1% SDS, 0.1% ammonium 
persulfate). Agarose (0.5%) was used to seal the strips. Following electorphoresis, the gels were 
stained with Deep Purple Total protein stain (GE-Amersham) and scanned using a Typhoon 
imager (GE Healthcare) at an excitation length of 528 nm. The scans were analyzed using Image 
Master Platinum 2.0 software (GE-Amersham) and spots unique to the Robo502-912-infected 
cells lysate were isolated using an ETTAN spot-picker. Protein plugs were stored in 4oC until 
analysis was done by trypsin digestion and Matrix Assisted Laser Desorption Ionisation mass 
spectrometry (MALDI-TOF) (Morehouse School of Medicine).  
Concentration of RUBV cytopathic vacuoles (CPV) in cell lysates 
A previously described method for concentration of a lysosomal fraction from cell lysates 
[14] was used to concentrate RUBV CPVs from Robo502 and Robo502-912 virus-infected cell 
lysates. Ten 100 mm culture plates of Vero cells infected with Robo502 or Robo502-912 virus 
(MOI ~1 pfu/cell) were harvested at 48 hours post-infection by using a cell scraper after being 
washed twice with PBS. The detached cells were collected in cold fractionation buffer (10 mM 
tris(hydroxymethyl)aminomethane/acetic acid pH 7.0,  250 mM sucrose) and washed twice in 
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fractionation buffer by low speed centrifugation. Cold fractionation buffer was also used in the 
following procedures. The washed cells were resuspended in 5 ml of buffer containing 1X broad 
range protease inhibitor (ROCHE) and cells were homogenized by 10 strokes in a 15 ml 
disposable tissue grinder system (VWR).  The cell homogenate was centrifuged at 2000 X g for 
2 minutes to remove debris and then at 4000 X g to pellet a combination of nuclei and cell 
membranes. The supernatant was collected and transferred to Beckman 3.9 ml Quick-Seal 
centrifuge tubes which were sealed and centrifuged at 100 000 X g for 2 min in a Beckman 
TLN100 rotor to pellet the mitochondria, endosome and lysosomes, all organelles associated 
with RUBV CPVs. The resulting pellet (P100) was resuspended in 0.75 ml RIPA buffer (10 mM 
Tris-HCl pH 7.4, 150 mM NaCl, 3 mM EDTA, 1% Triton X-100, 0.1% SDS, and 0.5% DOC) 
containing 1X broad range protease inhibitor (ROCHE) at 40C to solubilize the CPVs along with 
associated proteins from the pellet fraction. After centrifugation at 13,000 rpm for 5 minutes 
(Eppendorf tabletop centrifuge), the solubilized fractions were immunoprecipitated with anti-
FLAG monoclonal antibody-conjugated agarose beads (SIGMA) for 4 to 6 hours at 4oC. The 
precipitate was then washed 5 times with RIPA wash buffer (10 mM Tris-HCl pH 7.4, 150 mM 
NaCl, 0.5% Triton X-100, 0.5% DOC, and 3 mM EDTA).  Bound proteins were eluted by 
addition of 2X SDS-PAGE loading buffer (100 mM Tris-HCl pH6.8, 20 mM dithiothreitol, 4% 
SDS, 0.2% bromophenol blue, and 20% glycerol) and boiling. Eluted proteins were resolved on 
6% and 10% SDS-PAGE gels, stained with GelCode Blue (Pierce) and scanned with a Typhoon 
imager (GE Healthcare) using no filter and an excitation wavelength of 633nm. Lanes containing 
proteins isolated from Robo502 and Robo502-912 infected cell pulldown samples were 
compared. Protein bands were excised from the gel using a clean scalpel and sent to the Scripps  
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Center for Mass Spectrometry, California. Excised protein bands were sent in deionized water, in 
1.5 ml eppendorf tubes. Protein identification was performed by the center using nano-
LC/MS/MS. 
Western blot analysis 
Proteins were separated by SDS-PAGE and then electorphoretically transferred to 
nitrocellulose membranes (Whatman) with a mini Protean II apparatus (Biorad) using 1X 
transfer buffer (25 mM Tris pH 7.5, 0.192 M glycine, 20% methanol) at 100V for 1 hour.  The 
membrane was blocked overnight with 5% dried milk in TBS (20 mM Tris-HCl, pH 7.5, 175 
mM NaCl) and the blot was probed with mouse anti-FLAG monoclonal antibody (Sigma), goat 
anti-VPS16 polyclonal antibody (IMGENEX), rabbit GU-8 anti-RUBV P90 antibody [17] or 
rabbit anti-Lamp2 polyclonal antibody (Abcam), each diluted 1:1000 in antibody dilution buffer 
(1% non-fat milk powder, 0.02% sodium nitrate in TBS buffer [20 mM Tris-HCl, pH 7.5 and 
175 mM NaCl]). The  proteins were detected using a BCIP/NBT (Roche) colorimetric assay with 
alkaline phosphatase-conjugated anti-mouse, anti-goat or anti-rabbit alkaline phosphatase 
conjugated secondary antibody (Promega) (1:5000 dilution).  
Electron microscopy of the P100 pellet to detect the presence of CPVs 
The P100 pellet fraction from uninfected or Robo502-912-infected Vero cells was fixed 
in 4% glutharaldehyde-PBS, and sent in an eppendorf tube to Dr. Cristina Risco, Center for 
Biotechnology, Universidad Autonoma, Cantoblanco Campus, Madrid, Spain, for analysis by 
transmission EM. 
Immunofluorescence assay of P100 pellet with dsRNA antibody 
Confirmation of the presence of dsRNA in the CPV-concentrated fraction (P100 pellet 
fraction) (as an indication of the presence of active replication complexes) was done using 
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antibodies specific for dsRNA in an immunofluorescence assay (IFA). A small amount of the 
P100 pellet fraction from uninfected or infected cells was smeared onto an 18mm glass coverslip 
followed by fixation with 4% paraformaldehyde in PBS for 30 min at 4oC. The coverslips were 
washed with PBS and incubated PBS-0.25% saponin for 10 min at room temperature to 
permeabilize the membrane bound CPVs. Coverslips were washed again with PBS and blocked 
with PBS, 2% BSA, 0.25% saponin for 30 min at room temperature. Primary antibody to 
dsRNA, a monoclonal mouse anti-dsRNA antibody (J2 from Biocenter, Szeged Hungary), was 
diluted in PBS, 0.1% BSA and 0.25% saponin (1:500 dilution) and added to the coverslips for 1 
hour. After three washes in PBS, secondary mouse anti-FITC antibody (SIGMA) diluted in PBS, 
0.1% BSA, 0.25% saponin (1:1000) was added followed by incubation for 30 minutes at room 
temperature.  The coverslips were washed with PBS, inverted and mounted onto glass slides with 
ProLong gold anti-fade reagent (Molecular Probes/Invitrogen). The cells were visualized with a 
Zeiss Axioplan 2 microscope with epifluorscence capacity using the 20 X objective.   
Results 
Identification of host proteins co-immunoprecipitating with P150 by 2D gel electrophoresis 
 The initial strategy employed to identify host cell proteins interacting with the RUBV 
P150 nonstructural replicase protein was co-immunoprecipitation from cytoplasmic lysates of 
RUBV-infected cells.  Advantage was taken of the development of RUBV constructs with an 
epitope tagged P150 that exhibit no difference in titer from corresponding constructs without the 
tag [18]. The proteins encoded by the constructs used in this study are shown in Fig 2.1. Since 
virus infection alters the infected cell, cells infected with the standard virus without the tag were 
used as the control rather than uninfected cells.  In this way, any host proteins that cross react 
with the antibody used in immunoprecipitation and are released or relocalized by virus infection 
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will not be misidentified as proteins co-immunoprecipitating through an association with P150.  
Infected cells were harvested 48 after infection because it was previously established that 
maximal levels of P150 expression occur at this time point [17]. 
 Fig. 2.2 describes the protocol used to identify host proteins co-immunoprecipitating with 
P150 separated by two-dimensional gel electrophoresis (2-DE).  The primary limitation in 
resolving proteins using 2-DE is that the proteins cannot be denatured prior to electrophoresis in 
the first dimension since this separation is based on isoelectric focusing under high voltage.  In 
total, co-immunoprecipitation followed by isoelectric focusing and separation of 
immunoprecipitated proteins according to molecular weight was conducted.  The pair of gels 
with the best resolution is shown in Fig. 2.3A.  As can be seen, background (ie spots present in 
both gels) was high. However, the Image Master Platinum 2.0 program that was used to compare 
protein spots present on “control” and “sample” gels was able to identify 17 protein spots 
specifically immunoprecipitated by anti-FLAG antibody from Robo502-912-infected cells.  
Although these spots are all marked in the gels shown in Fig. 2.3A, blow ups of regions 
containing the spots specific to the Robo502-912 gel are shown in Figures 2.3B through 2.3G.  
These unique spots were picked and analyzed by trypsin digestion and mass spectrometry. Each 
protein spot analyzed by mass spectrometry contained more than one possible “hit” or protein 
prediction. Only proteins that had a score more than 10 were considered valid and the most 
probable protein hit for each spot is listed in Table 2.1. As can be seen, 13 out of 17 hits had low 
scores, ie. ~10.  Many of these spots had a number of possible hits for protein identities with 
slightly lower scores than the one listed.  The low scores for protein identity hits from these spots 
could be due to more than one protein in a spot or low abundance of the protein in the spot.  In 
this regard, it should be noted that some of the unique spots were very close to larger spots 
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present in both the control and experimental gels (e.g. spots 258, 291, 471, 472, and 477; Fig. 
2.3A). Out of the 17 protein IDs however, 4 had scores that ranged from 16 through 58 and were 
considered possible P150 interacting candidates.  
 Of the four spots that yielded identity hits with scores >10 (spot 97, vacuolar protein 
sorting protein 16 with a score of 16.09; spot 59, zinc finger protein 43 with a score of 18.06; 
spot 85, B cell lymphoma CLL/lymphoma 11A isoform with a score of 18.08; and spot 62, 
follistatin-like 5 with score of 58) vacuolar protein sorting protein 16 (Vps16, spot 97) was 
chosen as a candidate protein to test further for association with P150 because its function was 
consistent with formation of vesicles by the RUBV replication in association with lysosomes and 
antibody to this protein was commercially available. Vps16 has been characterized as one of the 
class C Vps genes involved in multiple vesicle transport pathways, particularly involving the 
biogenesis and stability of lysosomal vesicles. It also serves as the delivery pathway for 
lysosomal proteins [19, 20]. In the Western blot used to confirm the binding of Vps16 to FLAG-
tagged P150, the anti-Vps16 antibody was capable of detecting the protein in cell lysates 
(indicated by arrow in the Western blot of Fig. 2.4). However, when P150 was 
immunoprecipitated from lysates of Robo502 or Robo502-912-infected cells, co-
immunoprecipitation of Vps16 with FLAG-tagged P150 did not seem to occur (lane 2, Fig. 2.4). 
There were two protein bands detected in lanes 1 and 2 at a higher molecular weight than the 
positive control band in lane 3. We do not know what protein these bands represented. 
Overall, the strategy of co-immunoprecipitation and 2-DE to detect host proteins 
interacting with P150 was too cumbersome, not routinely reproducible, and plagued by high 
background and therefore another approach was chosen to identify proteins associating with 
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P150, namely concentrating the CPVs in which RNA synthesis occurs prior to co-
immunoprecipitation. 
Identification of host proteins co-immunoprecipitating with P150 following concentration of 
CPVs by 1D gel electrophoresis 
 Fig. 2.5 shows a schematic of the new approach that was used to concentrate CPVs prior 
to co-immunoprecipiation with FLAG-tagged P150.  This approach was adapted from a 
published protocol used to isolate fractions containing lysosomes and endosomes as well as 
mitochondria and was shown to work successfully with different types of cell lines [14]. 
Basically, the protocol involved cell lysis by Dounce homogenization followed by two low speed 
centrifugations and then a high speed centrifugation. Lysosomes, endosomes and mitochondria 
remain in the supernatant following the two low speed centrifugations (S1 and S2) and 
concentrate in the final pellet following the high speed centrifugation (P3).  As shown in Figures 
2.6 and 2.7, FLAG-tagged P150 in Robo502-912 infected cells was present in equal amounts in 
the supernatant and pellet following the first centrifugation that cleared unlysed cells and other 
debris, but subsequently the majority distributed into the post-nuclear supernatant (S2) following 
the second low speed centrifugation and the pellet (P3) following the high speed centrifugation, 
as expected.  No P150 could be detected by the anti-FLAG antibody in any fractions from cells 
infected with Robo502, which expresses an untagged P150.  
 To confirm that the P3 fraction contained lysosomes, a Western blot was probed with 
antibodies against Lamp2 protein, a lysosomal membrane associated glycoprotein that is used as 
a lyosomal marker. Results shown in Fig. 2.8 confirmed the presence of Lamp2 in the P3 
fraction, but not the S3 fraction. This is pertinent to our goal of isolating RUB P150 associated 
with replication complexes because RUBV forms replication complexes in vesicles associated 
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with lysosomes [21]. However, the amount of Lamp2 protein in the Robo502 P3 fraction was 
lower that the amount in the Robo-502-912 P3 fraction, and is most probably a result of unequal 
amounts of protein samples being loaded during this one experiment. To further show that 
replication complexes were isolated using the fractionation protocol, the P3 fraction was fixed 
and analyzed by electron microscopy (Fig. 2.9) and an immunofluorescence assay (IFA) (Fig. 
2.10) to detect dsRNA, a marker of RNA-dependent-RNA synthesis. As shown in Figures 2.9 A, 
B and C, structures similar to CPVs seen in RUBV-infected cells (Fig. 2.9D) were detected in 
the P3 fraction from Robo502-912-infected cells, but not in the corresponding P3 fraction from 
control uninfected cells (Fig. 2.9E). When fixed smears of P3 fractions were probed with an 
antibody to double stranded RNA (dsRNA), the fraction from Robo-502-912-infected cells 
contained multiple distinct bright spots not seen in the fraction from control uninfected cells 
suggesting the presence of dsRNA in the infected samples (Fig. 2.10). Taken together, these data 
demonstrate that viral replication complexes were present in the P3 fraction.  
 The P3 fraction from Robo502 and Robo502-912-infected cells was next used for 
experiments to detect interactions of host cellular factors with P150 by co-immunoprecipitation 
following the approach diagrammed in Fig. 2.11.  First, the P3 fraction was solubilized with 
various lysis buffers to maximize the recovery of P150 as shown in Fig. 2.12.  Maximal recovery 
was obtained using the RIPA buffer that had been used to produce whole cells lysates in the 2-
DE analysis. Maximum recovery was desired to increase the chances of being able to detect the 
presence of host cellular proteins that may reside in the RC. However, to ascertain that the 
process yielding maximum recovery did not affect the binding of RUBV P150 with other 
proteins, the interaction of a the viral P90 which is known to bind P150 was tested. RUBV P90, 
the functional replicase protein [22], should be present in the replication complex [17] and 
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therefore should be present in the same fraction as RUBV P150. Fig. 2.13A (lane 4) and Fig. 
2.13B (lanes 9 and 10) show that P150 and P90, respectively, were present in the same fraction 
(supernatant fraction) of RIPA buffer solubilized P3 fraction. As shown in Fig. 2.13B, P90 was 
detected in solubilized P3 fraction of both Robo502 and Robo502-912-infected cells.  P90 was 
detected in both because the Western blot was probed with GU8, a rabbit polyclonal antisera 
against bacterially expressed RUBV P90. To determine whether the extraction method perturbed 
the physical interaction of RUB P150 with RUB P90, immunoprecipitation was done with anti-
FLAG antibody followed by Western analysis to detect the presence of both P150 and P90 using 
mouse anti-FLAG and rabbit anti-GU8 antibodies, respectively (Fig. 2.14 A and 2.14 B, 
respectively). Lane 2 of Figure 2.14A shows that P150 was successfully immunoprecipitated 
from the solubilized supernatant of the P3 fraction, while Lane 4 of Fig. 2.14B shows that P90 
was co-precipitated with P150. This experiment demonstrated that the interaction of RUBV P150 
with a known interacting protein, i.e. RUB P90, was preserved during the preparation of the 
CPV-containing fraction and subsequent extraction of P150 from the fraction. Therefore it could 
be postulated that the interactions of other binding partners of P150 would be similarly 
preserved. 
 Next, we wanted to see if host cell proteins were immunoprecipitated with RUBV P150 
from the CPV fraction. Fig. 2.15 shows SDS-PAGE separation of the proteins that were 
immunoprecipitated by anti-FLAG antibody from the solubilized P3 fraction from Robo502 
(Lane 1) and Robo502-912 (Lane 2) infected cells.  As can be seen, the subcellular fractionation 
and concentration of CPVs substantially reduced the background encountered when 
immunoprecipitation was done from unfractionated cell lysates (Fig. 2.3).  Two protein bands 
were detected in the Robo502-912 lane that was not present in the Robo502 control lane. One of 
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these protein bands (CPV1) migrated between the 116 kDa and 202 kDa MW markers while the 
second (CPV2) migrated slightly more rapidly than did the 98 kDa MW marker. Trypsinization 
and mass spectrometry nano-LC/MS/MS analysis of CPV1 and CPV2 identified both proteins as 
the RUBV P90 replicase protein with 95% confidence (Table 2.2). While the Mr of the CPV2 
band corresponded with the molecular weight of P90, the Mr of CPV1 did not and was indicative 
of P150.  However, a western blot of an 18x16 cm SDS-PAGE gel similar to the one used to 
resolve proteins for mass spectrometry analysis probed with mouse anti-FLAG antibody to 
identify the location of FLAG-tagged P150 showed that the Mr of P150 was very similar, but 
possibly slightly less, than that of CPV1 (Fig. 2.16).  We concluded that CPV1 most likely was a 
dimer of P90 which would have a Mr of 180 kDa (Fig. 2.16 B, indicated in asterisk).  
Nevertheless, P90 was the only pairing partner of P150 that was identified with the technique 
and protein staining reagent that we used for this particular experiment. No other proteins with 
molecular mass lower that 90 kDa, were found to interact with P150 (data not shown). 
Discussion  
 The goal of this study was to identify host cell proteins that interact with RUBV proteins 
and play an important role in viral replication.  Previous studies on the interactions of host 
factors with RUBV components identified cellular proteins that bind to the 5’ and 3’ untranslated 
regions (UTR’s) of the RUBV genomic RNA and to the P90 replicase protein and the C protein. 
Specifically, La autoantigen bound to the 5’ UTR [23] and calreticulin bound to the 3’ UTR [24]. 
These associations were discovered by introducing radiolabeled RNA probes into cell lysates 
and detecting binding in gel mobility shift assays.  Binding of the retinoblastoma protein to P90 
was found based on bioinformatics predictions of binding motifs for this protein in the P90 
protein while binding of citron kinase to P90 was identified through yeast two-hybrid assays [25, 
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26].  Finally, binding of mitochondrial p32 to the C protein was discovered using a yeast two-
hybrid assay and the binding of polyA binding protein to C protein was discovered by using a 
GST-capsid fusion protein expressed in mammalian cells and affinity purification of capsid-
binding partners (in the transfected cells) on gluthathione agarose beads [27, 28].  Despite 
follow-up studies, the role that any of these proteins plays in RUBV replication has not been 
determined. We reasoned that a more promising way of isolating cell proteins directly involved 
in RUBV replication would be by co-immunoprecipitation with the RUBV replicase from lysates 
of infected cells in which virus replication was ongoing. We took advantage of the recent 
successful insertion of an epitope tag into one of the RUBV replicase proteins, P150, without 
compromising viral RNA infectivity and used a virus expressing a FLAG-tagged P150 in this 
study.  Similar approaches have been taken with other viruses, e.g. the alphavirus Sindbis virus, 
albeit with a GFP tag [29, 30]. 
 The first approach taken in this Specific Aim was to resolve proteins co-
immunoprecipitating with P150 from cytoplasmic lysates of RUBV-infected cells by two-
dimensional electrophoresis (2-DE), a method which first resolved proteins first by iso-electric 
focusing (charge) and then by molecular mass. The primary advantage conferred by this method 
is a better separation of proteins compared to the traditional one dimensional SDS-PAGE.  2-DE 
also allows the identification of post-translational modifications such as phosphorylation and 
glycosylation on a single species of protein. 2-DE was first introduced by P.H. O’Farrel and J. 
Klose in 1975 [31, 32]. A modification of this original method by Angelika Gorg [33] provided 
an easier way to separate proteins on the first iso-electric dimension and, as a result, more 
consistent patterns of proteins were seen. The traditional method relied on a mixture of carrier 
ampholytes to facilitate the iso-electric focusing of proteins that led to long focusing times and 
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modifications of pH gradients that caused non-reproducible results. Commercial immobilized pH 
gradients (IPG) with the modifications of Angelika Gorg overcame some of the limitations posed 
by the traditional method of iso-electric focusing. Nevertheless, many steps are necessary to 
prepare the immunoprecipitated samples properly to retain the native conformation for 
successful resolution in the first dimension. The majority of research that utilizes this method 
involves detecting differential expression of proteins in cells, for example tumor versus non-
tumor cells or infected versus non-infected cells.  However, 2-DE has been used as a tool to 
study protein-protein interactions as well.  For example, two studies, from which we derived our 
approach, were from labs that studied the interactions of host cellular factors with the HCV 
NS5A replicase and core protein [16, 34].  
  As a control for detecting non-specific co-immunoprecipitation by the FLAG-
monoclonal antibody-conjugated agarose beads from lysates of Robo502-912-infected cells, 
lysates were used of cells infected with Robo502, which lacked a FLAG epitope. A non-epitope 
tagged virus was used as a control for changes in intracellular expression and redistribution of 
cellular factors that may occur as a result of infection. Most researchers doing similar studies 
have used lysates from uninfected cells as a control [35, 36] and have failed to take into account 
the changes in cells caused during infection. As a result, these studies yield higher levels of false 
positives 
The 2-DE gels yielded a large number of background spots; however, comparison of 
proteins immunoprecipitated from lysates with non-tagged and tagged P150 led to the 
identification of seventeen unique protein spots that were present in the latter. These spots were 
visible by staining with deep purple (GE-Amerham), a fluorescent stain that detects proteins at 
concentrations as low as 50 pg. Even though staining by this method increases sensitivity (low 
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detection limits), it increases background and as a result, produces false positives. The seventeen 
spots were picked and analyzed though trypsin digestion and MALDI-TOF analysis. However, 
the end result for most (thirteen) of the spots was more than twenty proteins as a possible 
identity for each spot with relatively low scores for each, suggesting that the  concentration of 
the proteins in the spot were low and/or contaminated by proteins in nearby background spots. 
There are several possible reasons for this finding. Firstly, the many steps that were involved 
before the proteins in the sample could be focused on the first dimension could have led to the 
loss of important binding proteins. Secondly, the decrease in the amount of real binding proteins 
led to masking by proteins that were initially present as non-specific proteins. Finally, the high 
sensitivity of the staining method gave an illusion of abundance when actually low levels of real 
binding proteins existed to begin with. To add to these factors, when the proteins are processed 
through trypsin digestion and further repetitious steps for peptide purification using ZipTip 
(Millipore), the amount of peptides available for identification become even less.   
Despite the low confidence in the proteins identified from thirteen of the seventeen spots, 
the top candidates from the remaining spots had higher scores. Some of the proteins with higher 
scores were vacuolar protein sorting protein 16 (Vps16) with a score of 16.09, zinc finger protein 
43 with a score of 18.06, B cell lymphoma CLL/lymphoma 11A isoform with a score of  18.08 
and follistatin-like 5 with score of 58.10. Other than Vps16, not much has been reported in the 
literature about the functions of the other identified proteins, nor were there any reagents readily 
available to test their binding to P150. Thus, Vps16 was chosen for further analysis because it 
functions in protein transport between the Golgi and vacuolar organelles (e.g., endosomes, the 
sites of RUBV RC assembly) and an antibody was available.  However, we were unable to 
obtain data indicating that Vps16 interacted with P150 by co-immunoprecipitation.  
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 The high background encountered following co-immunoprecipitation from lysates of 
infected cells along with the problems encountered with 2-DE (amount of effort, lack of 
reproducibility, and unconvincing protein identities from unique spots) led us to choose another 
approach to detect proteins interacting with P150, namely a fractionation protocol designed to 
concentrate endosomes and lysosomes, the precursors of RUBV CPVs that house the RCs.  Such 
a procedure should reduce background which would allow us to use 1-D SDS-PAGE to resolve 
proteins co-immunoprecipitating with P150 (the method most commonly employed currently in 
similar studies on other viruses [29, 30]).  Additionally, one of the limitations posed by 2-DE 
method is the under-representation of membrane proteins due to poor solubility and aggregation 
which makes it difficult for these proteins to enter the second dimension from the IEF strip [33, 
37]. This is a significant problem as far as our research is concerned simply because P150 is a 
membrane-associated protein (unpublished data) and viral RNA replication in RUBV infected 
cells occurs in association with membranes [2, 38]. Thus, immunoprecipitation of P150 from a 
CPV-enriched fraction followed by SDS-PAGE, rather than 2-DE, increased the chances of 
identifying membrane proteins associated with P150.  Furthermore, recent studies have shown 
that only a fraction of SINV non-structural proteins are present in CPVs and the rest are present 
in the cytoplasmic locations other that the modified lysosomes [6]. Similarly RUBV P150, it has 
been shown to exist both as punctuate foci in the cytoplasm of infected cells, which likely 
correspond to CPVs, and in fibrous structures, particularly late in infection when we made our 
lysates [7]. These different intracellular locations of P150 suggest that the protein is involved in 
different stages of virus replication at different times post-infection. Therefore our approach of 
isolating CPVs prior to studying host factors interacting with P150 in the replication complex 
was more likely to yield information on host factors that participate in virus RNA synthesis.  
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As discussed in Chapter 1, co-immunoprecipitation was used to identify cell proteins that 
interacted with two of the nonstructural replicase proteins of the alphavirus, SINV, namely nsP2 
and nsP3, both of which were successfully tagged with GFP without compromising virus 
infectivity.  While a plethora of cell proteins were identified as interacting with nsP2 and nsP3, 
including cytoskeleton proteins, chaperones, elongation factor 1A, heterogeneous nuclear 
ribonucleoproteins, 14-3-3 proteins, and some of the ribosomal proteins [29, 35, 39], emphasis 
was placed on G3BP1 and G3BP2 and the the mosquito cell homolog, Rasputin [29, 30]. The 
association of these proteins with both nuclear pores and stress granules led to the hypothesis 
that recruitment of these proteins by the SINV nonstructural proteins played a role in shutoff of 
nuclear transcription and/or reformatting the translational capacity of the cell to favor translation 
of virus proteins.  Overall, these co-immunoprecipitation studies emphasized the complexity of 
the interaction between virus and cell proteins. However, a definitive role was not established for 
any of these proteins in virus replication. More convincing was the cell fractionation study that 
identified hnRNP-K, along with stress response and cytoskeletal proteins, as a protein enriched 
in membrane fractions harboring active SINV RCs [36].  It was subsequently shown that hnRNP 
K co-immunoprecipitated with the SINV nonstructural proteins and the subgenomic (but not the 
genomic) RNA and it was hypothesized that it played a role as part of the RC in regulating the 
ratio of genomic and subgenomic RNA synthesis and subsequent subgenomic RNA translation. 
The architecture of alphavirus CPVs was described as early as 1968 [40, 41] and 
subsequent literature added to the description, primarily using electron microscopy and immuno-
electron microscopy [5, 42]. Active alphavirus RCs form in membrane limiting regions of 
modified vacuoles and were termed CPV-I.  These vacuoles were later shown to be derived from 
lysosomes. Since lysosomes evolve from endosomes, it was thought that initial formation of RCs 
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within endosomes resulted from virus entering the cell through receptor mediated endocytosis. 
However, this idea did not hold water because the multiplicity of infection did not correspond 
with the number of CPVs that were formed [42]. Additionally, CPVs are formed following 
transfection of virus RNA, indicating that their formation was a post-translational event not 
dependent upon initial localization of virions to an endosome or lysosome.  CPVs are 
approximately 0.6-2.0 µm in diameter and the actual sites of RNA synthesis are membrane-
bound spherules 50 nm in diameter that line the inner surface of the CPV vacuole at regular 
intervals. As for RUBV, CPVs resembling those produced by alphaviruses have been visualized 
in cells following both transfection and infection [2, 3].  The CPVs are derived from lysosomes 
and the spherules contain dsRNA and both the P150 and P90 replicase proteins. In order to 
isolate these CPVs, we took advantage of a previously established differential centrifugation 
method for fractionation of endosomes, lysosomes and mitochondria from a variety of eukaryotic 
cell lines [14]. 
When this fractionation method was applied to a post-nuclear supernatant, P150 
segregated quantitatively into the subsequent P3 or “P100” pellet fraction expected to be 
enriched for endosomes, lysosomes, and mitochondria. In confirmation, we showed that this 
fraction contained the Lamp2 protein, which is a marker for lysosomes. We next sought physical 
evidence of the presence of CPVs through electron microscopy and indeed the P100 fraction 
contained vacuolar structures  comparable to previously published electron micrograph images 
of RUBV CPV that were not present in the corresponding P100 fraction from uninfected cells 
[3]. The presence of replication complexes in the P100 fraction was supported by a novel 
experiment whereby the P100 fractions of both control as well as infected Vero cells were fixed 
and stained with antibodies to double stranded RNA; bright green spots in P100 fractions from 
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infected cells and not from the control cells were observed. Based on all these observations, we 
concluded that the P100 fraction contained active replication complexes. 
The next challenge was to extract P150 from the membranous CPV while maintaining 
important binding partners. The P100 fraction was solubilized using three different lysis buffers 
to maximize the extraction of P150. Co-immunoprecipitation of P90 was evaluated as a positive 
control and also to ensure that the solubilization technique did not disrupt the potential binding 
partners of P150. Standard RIPA buffer containing both 1% Triton X-100 and 0.5% DOC was 
the most successful in extracting P150 from the membranous complex. This finding was in 
agreement with a previously published paper on the successful recovery of functional replication 
complexes from alphavirus infected cells [43]. In this paper, RIPA buffer in the presence of 1% 
Triton X-100 and 1% DOC was successfully used to extract replication complexes from a P15 
fraction of alphavirus infected cells yielding all of the nonstructural proteins nsP1, nsP2, nsP3, 
nsP4 and some nsP34, and an unidentified protein (~120 kDa) believed to be a host cellular 
protein.   
In our study, after confirming that the solubilized P100 fraction contained both P150 and 
P90 and that P90 co-immunoprecipitated with P150, we proceeded to use 1-D SDS-PAGE to 
resolve putative cell proteins co-immunoprecipitating with P150 for subsequent identification by 
mass-spec analysis.  SDS-PAGE analysis of proteins immunoprecipitated by anti-FLAG 
antibody revealed that cell fractionation substantially reduced the background present following 
similar immunoprecipitation from unfractionated, cytoplasmic lysates. Two protein bands were 
found to be immunoprecipitated by anti-FLAG antibody specific for Robo502-912. These two 
proteins were identified as RUBV P90. While the molecular mass of CPV2 fit that of P90, the 
identification of CPV1 as P90 was not expected. Further analysis of the protein band in the 
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CPV1 region, led us to identify an additional band above the one where the presence of P150 
was confirmed through Western blot analysis. P150 may not have been identified through mass-
spectrometry because the protein band that was excised for analysis may have contained the 
protein from the higher molecular mass. We hypothesized that the CPV1 protein band that was 
identified could be a P90 dimer. The high confidence level (95%) of a number of peptides that 
matched P90 and the molecular mass of the protein, support our hypothesis. However, further 
analysis needs to be done to confirm this hypothesis.  
However, these data do not mean that host proteins are not involved in the replication of 
virus genome. Host cellular factors have been shown to interact, as described earlier, with the 5’ 
UTR and 3’ UTR of a virus genome. Specific template recognition by a virus RdRp is important 
to ensure that replication occurs properly. Some of the factors that are important in this respect 
are the sequences and secondary structures present at the 5’ end and the 3’end of the genome.  
Binding of host cell proteins to these RNA sequences/structures and to the RDRP itself could 
function to direct the RdRp to the template to promote template specifity as well as to form an 
active replication complex [1, 44, 45]. In the classic example of the replicase of bacteriophage 
Qβ, the binding of host cellular elongation factors EF-Tu, EF-Ts and ribosomal protein S1 to the 
Qβ replicase is important for the formation of the holoenzyme and synthesis of plus strand RNA 
from negative strand template [46]. The binding of another host factor, HF1, a ribosomal protein 
to the 3’ end of this RNA genome is required for negative strand RNA synthesis [47].  An 
analysis of RCs formed by flock house virus (FHV), a nodavirus that included electron 
tomography, it was concluded that in the 50 nm spherules formed on the outer mitochondria 
membranes that comprise the RC that there was little or no room for any other factors other than 
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viral replicase protein and the virus RNA [48]. The 50 nm spherules that was studied in FHV are 
similar to the ones found to line the interior of CPVs in RUBV infected cells. 
While we found no host cell proteins interacting with P150 in the replication complex, it 
has to be pointed out that there were caveats to the approach and method that we used to isolate 
proteins from the RUBV infected cells. Firstly, even though the fractionation procedure reduced 
the amount of background for the immunoprecipitation experiment specific for Rob0502-912, it 
also reduced the amount of host proteins that may already have been low in abundance to begin 
with. As a result, the enrichment of viral proteins led us to detect P150 and P90 that were higher 
in abundance in that fraction, and not low abundance host proteins that were faintly detected 
using by GelCode Blue staining reagent. The second caveat to our method was the fractionation 
procedure itself. The high speed of the final fractionation step that led to the formation of the P3 
pellet may have perturbed host-virus protein interactions. Finally, the solubilization technique 
using denaturing detergents such as DOC and SDS to remove P150 from the P3 fraction may 
have disrupted important host-virus protein interactions as well. For future studies, analysis of 
the all the proteins enriched in the P3 fraction of RUBV infected cells could be done in 
comparison to a P3 fraction from uninfected cells. The entire set of proteins in a P3 fraction can 
now be analyzed by high performance liquid chromatography followed by peptide identification 
through tandem mass spectrometry. 
In conclusion for this aim, we did not find P150 binding to host cellular proteins in the 
context of CPVs. As will be seen from the data obtained for the second Specific Aim, P150 does 
bind to host cellular factors. However this interaction most probably does not occur in the 
context of P150 within the RC. P150 is located in different places and structures in the 
cytoplasm of the infected cells where it may have different functions.  In its role as a virus 
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replicase, P150 does not seem to form stable interactions that can be detected with the techniques 
used. The interaction of host cellular factors with P150 in its non-CPV form is further 
investigated in the next Specific Aim. 
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Figure 2.1. Genomic diagram of Robo502-912.   
Robo502-912, the experimental virus used in this study, contains a FLAG epitope 
inserted in a Not I site (nt 1684 and 1685) in the nonstructural replicase protein P150 
gene allowing detection of P150 produced by this virus by commercially available 
FLAG reagents. Insertion of the FLAG epitope tag did not affect the efficiency virus 
replication and virus titers obtained from this construct was comparable to those 
produced from the wild type Robo502 virus parent.  The Robo502-912 construct was 
developed by Dr. Wen-Pin Tzeng [9]. 
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Figure 2.2. Schematic showing the procedures used to identify host cell proteins binding to 
RUBV P150.  
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 Figure 2.3A. Two-dimensional gel electrophoresis analysis of proteins immunoprecipitating 
with RUBV P150.   
Robo502-912- (FLAG-tagged P150) and Robo502-infected cell lysates were 
immunoprecipitated using anti-FLAG antibody-conjugated agarose beads and resolved by 2-
DE analysis. Proteins were focused on 13 cm Immobiline strips (pH 3-10 non linear range) 
for the first dimension separation (horizontal), followed by second dimension separation 
(vertical) by 10% SDS-PAGE. The gel on the left is the control sample (Robo502 infected 
cells) while the one on the right is the experimental sample (Robo 502-912 infected cells). 
The gels were stained with deep purple fluorescence stain (GE-Amersham) and viewed with a 
typhoon imager (GE-Amersham). A total of 17 protein spots were identified using 
ImageMaster Platinum software (GE-Amersham). Protein spots unique to Robo502-912 
infected cells are enclosed within white boxes and the corresponding numbers were assigned 
by the software. Blow ups of regions of the gel containing unique spots are shown in Figs. 
2.3B through 2.3G. 
Robo502 Robo502-912 
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Figure 2.3B. Close-up of 2-DE gel shown in Figure 2.3A. 
Protein spots unique to Robo502-912 infected cells are enclosed within 
circles. 
Figure 2.3C. Close-up of 2-DE gel shown in Figure 2.3A. 
Protein spots unique to Robo502-912 infected cells are enclosed within circles. 
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Figure 2.3D. Close-up of 2-DE gel shown in Figure 2.3A. 
Protein spots unique to Robo502-912 infected cells are enclosed within 
circles. 
Figure 2.3E. Close-up of 2-DE gel shown in Figure 2.3A. 
Protein spots unique to Robo502-912 infected cells are enclosed within circles. 
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Figure 2.3F. Close-up of 2-DE gel shown in Figure 2.3A. 
Protein spots unique to Robo502-912 infected cells are enclosed within circles. 
 
Figure 2.3G. Close-up of 2-DE gel shown in Figure 2.3A. 
Protein spots unique to Robo502-912 infected cells are enclosed within circles. 
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Table 2.1. Mass-spectrometry identification of spots picked from a 2D gel (Fig. 2.3A) 
Proteins shown were identified as the top candidates for each of the spots. 
*VPS16 was chosen as a candidate protein to confirm interaction and test confidence levels 
of mass-spectrometry data. 
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Robo502 Lysate 
Vps16 
1 2 3 
Figure 2.4. Lack of co-immunoprecipitation of Vps16 with P150 antibody.  
 To test for association between Vps16 and P150, post nuclear fractions of Vero cells 
infected with Robo502 (lane 1, negative control) or Robo502-912 (lane 2, experimental 
sample) were immunoprecipitated with anti-FLAG antibody followed by SDS-PAGE and 
Western blot probed with anti-Vps16 antibody. Lane 3 contains uninfected Vero cell 
lysate to detect the presence of Vps16 protein. The absence of Vps16 in lane 2 indicates 
that FLAG tagged P150 does not specifically interact with this cell protein. The asterisks 
represent unknown protein bands that were immunoprecipitated by Robo502 and 
Robo502-912 (lanes 1 and 2). There appears to be a very faint protein band at the same 
location in lane 3 as well. This background protein band could have been enriched in the 
immunoprecipitated sample. 
Robo502-
912 
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Figure 2.5. Schematic showing the procedures used to fractionate cell lysates to produce a 
fraction enriched for membranous organelles such as endosomes, lysosomes, and mitochondria 
plus, putatively, RUBV-induced CPVs.   
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Figure 2.6. P150 distribution in subcellular fractions.   
Lysates of Robo502-912 and Robo502-infected Vero cells were fractionated following 
the procedure outlined in Fig. 2.5. A 1% aliquot (percentage value based on starting 
material) of each fraction (pellets were solubilized in SDS-PAGE sample buffer) was 
resolved by 6% SDS-PAGE gel followed by Western blotting probed with mouse anti-
FLAG antibody.  
Figure 2.7. P150 distribution in high-speed centrifugation fractions.   
After the final high speed centrifugation in the fractionation procedure outlined in Fig. 
2.5 for lysates of Robo502- and Robo502-912-infected Vero cells, proteins in the 
supernatant fraction were concentrated by acetone precipitation and resolubilized in 
SDS-PAGE sample buffer. The P3 pellet was also solubilized in the same amount of 
SDS-PAGE sample buffer.  Equal aliquots were then resolved by 6% SDS-PAGE 
followed by Western blotting probed with mouse anti-FLAG antibody.   
 
62 
                                    
 
 
 
 
 
 
 
 
 
 
                    
                      
                                                                                                                                                                                    
 
 
 
 
 
 
 
 
 
Figure 2.8. Presence of Lamp2 lysosomal marker in high-speed centrifugation fractions.   
After the final high speed centrifugation in the fractionation procedure outlined in Fig. 2.5 
using lysates of Robo502- and Robo502-912-infected Vero cells, the supernatant fraction 
was concentrated by acetone precipitation and resolubilized in SDS-PAGE sample buffer. 
The P3 pellet was also solubilized in the same amount of SDS-PAGE sample buffer.  Equal 
aliquots were then resolved by 6% SDS-PAGE followed by Western blotting probed with 
rabbit anti-Lamp2 polyclonal antibody. The amount of Lamp2 P3 fraction of Robo502 
appears less than amounts present in P3 fraction of Robo502-912. This is most probably a 
result of unequal amounts of protein samples present in each aliquot during this one 
experiment.    
 
Figure 2.9. Electron micrographs of subcellular structures present in the P3 pellet fraction.  
Following the fractionation procedure shown in Fig. 2.5, the P3 pellet fractions from 
uninfected and Robo502-912 infected Vero cells were fixed with 4% glutharaldehye in PBS 
and sent for transmission EM analysis to Dr Cristina Risco (Centro Nacional de 
Biotecnologia, Madrid, Spain).  Panels A, B and C show micrographs from Robo502-912-
infected cells while Panel E shows a micrograph from uninfected cells.  CPVs in the 
infected cells are indicated by arrows.  As a comparison, an electron micrograph showing 
the presence of cytopathic vacuoles (CPV) in RUBV-infected cells is shown in Panel D [3]. 
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Figure 2.10. Immunoflurescence assay to detect the presence of dsRNA in the P3 pellet 
fraction.   
Following the fractionation procedure outlined in Fig. 2.5, a small amount of the P3 pellet 
fraction from uninfected (A) or Robo502-912-infected (B) Vero cells was smeared onto an 18 
mm glass coverslip and fixed with paraformaldehyde.  To detect dsRNA, a replicative 
intermediate indicative of viral RNA replication, primary antibody to dsRNA, a monoclonal 
mouse anti-dsRNA antibody, was added followed by secondary anti-mouse FITC labeled 
antibody.  The coverslips were mounted onto glass slides with ProLong gold anti-fade reagent 
(Molecular Probes/Invitrogen) and visualized with a Zeiss Axioplan 2 microscope with 
epifluorscence capacity using the 20 X objective.   
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Figure 2.11. Schematic showing the procedure to optimize solubilization of the P3 
fraction prior to immunoprecipitation of P150.   
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Figure 2.12. Solubilization of the P3 pellet with different lysis buffers.   
Following the procedure outlined in Fig. 2.11, the P3 pellet from Robo502-912-infected Vero 
cells was solubilized with RIPA buffer (Lanes 1 and 4), RIPA buffer lacking SDS and DOC 
(lane 2)  or a buffer containing 2% CHAPS and 2% SB 3-10 (lane 3). After solubilization, 
equal volumes of the solubilized supernatants were resolved by 6% SDS-PAGE followed by 
Western blotting probing with mouse anti-FLAG antibody.  As can be seen, RIPA buffer gave 
the best yield.  
 
Figure 2.13. Distribution of P150 and P90 following solubilization of P3 fraction with RIPA 
buffer.   
The P3 pellet fraction from uninfected Vero cells or Robo502- or Robo502-912-infected Vero 
cells was solubilized with RIPA buffer and the resulting supernatants and pellets (see Fig. 
2.11) were resolved by 6% SDS-PAGE followed by probing with mouse anti-FLAG antibody 
(to detect P150, lanes 1-4) or rabbit polyclonal anti-P90 antibody (detects P90 synthesized by 
either Robo502 or Robo502-912, lanes 5-10).  As can be seen, both P150 and P90 were 
efficiently liberated from the pellet by RIPA buffer.   
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Figure 2.14. Co-immunoprecipitation of P150 and P90 following solubilization of the P3 
pellet.   
Following solubilization of the P3 fraction from Robo502- (lanes 1 and 3) or Robo502-
912- (lanes 2 and 4) infected cells with RIPA buffer (see Fig. 2.11), the supernatants were 
immunoprecipitated with anti-FLAG antibody to pull-down FLAG-tagged P150. The 
immunoprecipitated proteins were resolved by 6% SDS-PAGE followed by probing with 
mouse anti-FLAG antibody (to detect FLAG-tagged P150, Panel A) or rabbit polyclonal 
GU-8 antibodies (to detect P90, Panel B).  As can be seen, P90 co-immunoprecipitated 
with P150 following lysis of the P3 pellet with RIPA buffer.   
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   Figure 2.15. 1D SDS-PAGE of proteins immunoprecipitated with P150 in the P3 fraction of 
RUBV-infected cells.   
P3 pellet fractions from Robo502- and Robo502-912-infected Vero cells that had been 
solubilized with RIPA buffer were immunoprecipitated using mouse anti-FLAG antibody-
conjugated agarose beads and the immunoprecipitated proteins were resolved using 6% 
SDS-PAGE on a 18 X 16 gel format.  The gel was stained using GelCode blue and 
visualized using a Typhoon imager without any filters.  Two bands present in the Robo502-
912-infected cell lysate, but not in the Robo502-infected cell lysate, designated CPV1 and 
CPV2, were excised from the gel and sent for identification by trypsin digestion and mass 
spec. 
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Table 2.2. Mass-spectrometry identification of proteins co-immunoprecipitated with P150 
following cell fractionation to enrich for CPVs. 
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Figure 2.16. Comparison of SDS-PAGE of P150 and CPV1.   
To compare the Mr’s of P150 and the CPV1 protein band, proteins immunoprecipitated with anti-
FLAG antibody from P3 fractions prepared from Robo502- and Robo502-912-infected cells were 
resolved by 6% SDS-PAGE using the 18 cm X 16 cm format. The area in the region expected to 
contain P150 was excised and subjected to Western blotting probed with mouse anti-FLAG antibody 
(Panel A).  In comparison with the gel from which CPV1 was identified (Panel B), the presence of 
two bands in the CPV1 region was evident. During the process of excising protein band for mass-
spectrometry analysis, the lower band (representing P150) may have been excluded leaving the upper 
band (possibly representing P90 dimer) to be excised instead and identified. 
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CHAPTER 3 
Specific aims 2 and 3:  To investigate the importance of two SH3 binding domains within 
the RUBV P150 nonstructural protein in the virus life cycle and identify cell proteins with 
which they bind 
Introduction 
Proteins with SH3 domains often bind to ligands containing PxxP motifs in their amino 
acid sequence [1]. SH3 domains are 50 to 70 amino acids in length and are usually present in 
proteins in eukaryotic cells involved in signal transduction [2].  Similar SH3 structures have 
been identified in bacteria [3, 4] and are thought to play a role in bacterial pathogenesis upon 
infection of a eukaryotic host [5-7]. In addition to signal transduction, SH3 domains in 
eukaryotes are thought to play a role in directing cell compartmentalization [8, 9]. This 
hypothesis is based on the finding that SH3 domains are present in various cytoskeletal proteins.  
SH3 domains are composed of five β-strands and a single turn of helix [10]. This 
topology allows formation of two triple-stranded, anti-parallel β−sheets at right angles relative to 
one another creating hydrophobic pockets that bind PxxP motifs. The mechanism of PxxP 
binding to SH3 domains has been characterized [11-13]. PxxP motifs form a left handed helical 
structure with three residues per turn known as polyproline type II (PPII) helix. The PPII helix 
lacks intramolecular hydrogen bonds, allowing carbonyl groups to form intermolecular hydrogen 
bonds with target proteins. There are three binding pockets within an SH3 domain. Two of these 
bind the Px or xP element in the PxxP motif while the third binds to a flanking residue, usually 
an arginine, that is either before (RxxPxxP) or after (PxxPxR) the PxxP consensus sequence. The 
twofold pseudosymmetry of the PPII structure allows it to bind to target SH3 domains in two 
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different orientations, ie in an N- to C-terminal orientation or vice versa. This allows flexibility 
in binding to a protein with an SH3 domain and may also contribute to the same binding partners 
having two different functions. Proline is also unique in comparison to other amino acids 
because it possesses a five-member ring fused onto the nitrogen, making it a secondary amine. 
This feature allows other proteins to bind to the carbon fused to nitrogen without having to make 
contact with the rest of the side chain and as a result allows for specific, low affinity interactions 
to occur [1]. All these features make P-X-X-P domains, and the proline rich region of proteins 
that contain them, excellent candidates for specific yet weak binding by other proteins [1], a 
necessity for proteins involved in signal transduction as a quick and readily reversible, yet 
specific, response is required. 
PxxP consensus sequences present in viral proteins have been shown to bind host 
proteins with SH3 domains [13-17]. Examples of viral proteins with a PxxP consensus sequence 
that have been found to interact with known cell protein SH3 domains are human 
immunodeficiency virus (HIV) Nef protein, bovine leukemia virus (BLV) gp30 transmembrane 
protein, influenza A NS1 protein and hepatitis C virus (HCV) NS5A protein. The interaction of 
these viral proteins with host proteins containing SH3 domains has been shown to be important 
for virus replication as well as pathogenicity [14-17].  RUBV has a proline rich region (PRR) in 
its P150 non-structural replicase protein, stretching from amino acids 716 to 782 of the protein 
(which contains 1301 aa in total) (Fig. 3.1). Of the eleven PxxP motifs found in this region, three 
of the motifs fulfill the criteria for the class II binding ligand involving SH3 domains, i.e. 
PxxPxR. Based on previous findings that proline rich domains of other viral proteins have the 
ability to interact with host cellular factors that possess SH3 domains, with the result of 
modulating cell signaling [13, 15, 16, 18] it would not be unexpected to find that the P150 PRR 
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engages in similar interactions. The goal of this study was to investigate whether the putative 
SH3 binding domains in the RUB P150 PRR are of significance in the virus replication cycle. If 
so, it would be a novel finding in the Togaviridae family. 
Materials and methods 
Cells and virus 
 The 293-T line of transformed human embryonic kidney cells (HEK) (ATCC) was grown 
and maintained at 37oC with 5% CO2, in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) and penicillin-streptomycin (100 µg/ml). The 
Vero line of African green monkey kidney cells was grown and maintained at 35oC with 5% CO2 
in DMEM containing 5% FBS and gentamicin (10µg/ml). Two RUBV strains were employed:  
F-Therein, a wild-type strain, will be referred to as “RUBV” while “Robo502 virus” and its 
mutants are derived from an infectious cDNA clone.     
Mutagenesis of the Robo502 infectious cDNA clone  
 Site-directed mutagenesis was done to change both prolines in a P-X-X-P-X-R motif to 
alanines in the Robo502 infectious clone [19].  There are three of these motifs in the proline 
hinge region, termed Motif 1, Motif 2, and Motif 3, and the following primers were used to 
create proline to alanine mutations in each motif: 
Motif 1 mutation: 5’ CAC CCG GCG ACG CCC CGC CGG CGC GCC GCG CAC 3’ 
Motif 2 mutation: 5’ CGG CAC TCC GGC CCC CGC GGC TGC GCG CGA CC 3’ 
Motif 3 mutation: 5’ CCG CCC CCA GCG CGC CCG CGG CAC CCC GCG C TG 3’ 
These mutagenic primers were combined with forward  (5’CGC ATA CGT AGC CTT CCG 
CGC GTG G 3’; SnaBI site underlined) and reverse (5’ GTG GGG GCG GTC CGA GAC GC 
3’; Rsr II site underlined) primers in a protocol described previously [20]  that introduces 
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mutations using two rounds of PCR amplification in a single reaction tube. The amplification 
reaction included: 50-100 ng linearized Robo502 template, 1.0 pmol internal mutagenic forward 
primer (i.e. Mut1, Mut2, or Mut3),, 0.05 pmol reverse primer, 4 ul 2.5 mM dNTPs, 5 ul 10X Ex-
taq buffer (Takara), 10 ul 5X Q solution (Qiagen), 0.5 ul Ex-taq polymerase (Takara) and 29 ul 
dH2O . Briefly, the first round of PCR in which mutagenic and reverse primers were added, was 
done with using the following PCR parameters: 5 cycles of 950C for 1 minute, 600 C for 30 sec, 
720 C for 2 min followed by a final incubation at 72oC for 35 minutes. Following the final 35 
minute incubation step, 1 µl of 125 ng/µl forward primer was added and the reaction continued 
using the following protocol:  25 cycles of 960 C for 1 min, 650 C for 30 sec, 720 C for 2 min 
followed by 720 C for 10 min. The extended 35 minute incubation step in the first round of PCR 
helps the utilization of reverse and mutant primers so that only completed mutagenic 
megaprimers are present in the final step of the PCR reaction. PCR products were purified by 
phenol/chloroform extraction, precipitated with ethanol, and digested using Rsr II and SnaBI 1 
restriction enzymes (NEB). The resulting fragments were gel purified (Qiagen gel extraction kit) 
and reintroduced into Robo502 digested with the same restriction enzymes to replace the 
corresponding wt fragment.  Mutagenesis was confirmed by sequencing the entire length of the 
mutagenized fragment (done by the GSU core facility). The mutant constructs were named 
Mut1-Robo502, Mut2-Robo502 and Mut3-Robo502 for mutations made in the Motifs 1, 2 and 3 
respectively. To make constructs with mutations in motifs 1 and 2 or Motifs 1, 2, and 3 in 
combinations, a single mutant construct was used as the DNA template and mutations in the 
other motifs were made sequentially using the protocol described above. These constructs were 
named Mut1+2-Robo502 and MutX-Robo502 (triple mutant). 
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Construction of RUBV proline-hinge-GST fusion constructs 
 The putative SH3-binding domain in P150, between nucleotides 2189 through 2461 of 
the RUBV genome (between amino acid sequence 716 and 782), was amplified from the 
Robo502 template using forward and reverse primers that contain BamH I and Cla I restriction 
sites respectively: 5’GGA TCC TCC GCG GCC GCG TCA CCG CCA 3’ and 5’ ATC GAT 
GTC GCT GTC TGG GTC TGC CCT 3’. The amplified PCR product was digested with BamH I 
and Cla I (NEB), gel purified (Qiagen gel extraction kit) and ligated into a pEBG mammalian 
expression vector (provided by Dr Tom Hobman, U. Alberta) that was digested with the same 
enzymes, creating a construct termed GST-PRR/RUB.  A pEBG-Mut 1+2 construct was created 
using the strategy described above with the GST-PRR/RUB construct as the template, the 
forward and reverse primers used to amplify the sequence introduced into PRR/RUB, and the 
Mut1 and Mut2 mutagenic primers.  The mutation was confirmed by sequencing.  This construct 
was named GST-PRR/RUB MUT 1+2.   
Analysis of PRR mutations created in Robo502 
Ten ug of Robo502, Mut1-Robo502, Mut2-Robo502, Mut3-Robo502, double mutant 
Mut1+2-Robo502, and triple mutant MutX-Robo502 were linearized with EcoR I. The linearized 
templates were purified by phenol/choloroform extraction and precipitated by addition of 0.1 
volume of 3M ammonium acetate and 2.5 volume of ethanol. The precipitated DNA was 
dissolved initially in 40 µl of deionized water and after determination of the DNA concentration 
spectrophotometrically (O.D.260), the volume was adjusted to a final concentration of 250 ng/µl. 
Each template was used in the following in vitro transcription reaction: 5 µl of 5X transcription 
buffer (40 mM Tris-HCl [pH 7.5], 6 mM MgCl2, 2 mM spermidine) (Epicentre, Madison, Wis), 
2.5 µl of 100 mM DTT, 1.0 µl of RNasin ribonuclease inhibitor (Promega), 1.0 µl of 25 mM 
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NTPs (Amersham), 5.0 µl of 10 mM cap analogue [m7G(5′)ppp(5′)G] (New England BioLabs), 1 
µl of SP6 DNA dependent RNA polymerase (25U; Epicentre, Madison, Wis.), 2 µl of 250 ng/µl 
linearized template, and deionized water to make a final volume of 25 µl. The reactions were 
incubated for 1 hour at 37oC and the quality of the product was ascertained by agarose gel 
electrophoresis and ethidium bromide staining. Reaction mixtures were used directly for 
transfection.  Sixty mm culture plates of 100% confluent Vero cells were transfected with 30 µg 
of an RNA transcript from the wild type or mutant constructs using Lipofectamine 2000 
following the manufacturer’s recommended protocol (GIBCO BRL, Lifetechnologies). The cells 
were incubated with the transfection mixture for at least 4 hours after which transfection mixture 
was removed and replaced with Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 5% fetal bovine serum (FBS) and penicillin-streptomycin (100 µg/ml). The transfected cells 
were observed microscopically daily for development of cytopathic effect (CPE) and the 
medium was collected one week post-transfection; this was designated Passage 0 or P0. Titers of 
virus in the P0 medium were determined by plaque assay [21].  P0 medium was subsequently 
passaged by infecting 60 mm plates of Vero cell lines (P1) at a multiplicity of infection (MOI) of 
1 pfu/cell. Seven days post infection, the P1 medium was collected.  An aliquot of the P1 
medium was titered by plaque assay and total intracellular RNA was extracted from the infected 
cells using Tri-Reagent (Molecular Research Center, Inc) according to the manufacturer’s 
protocol. To produce a cDNA template for sequencing, reverse transcription was done using the 
following protocol: 5 µl of RNA solution was boiled for 5 minutes and then incubated on ice for 
5 minutes. One µl of reverse primer (5’ ATC GAT GTC GCT GTC TGG GTC TGC CCT 3’: nt 
2440-2467), 3 µl of deionized water, and 4 µl of 2.5 mM dNTPs were added followed by 
incubation at 65oC for 8 minutes. The reaction was cooled in ice and 4 µl of 5X first strand 
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buffer (Invitrogen), 1 µl of 0.1 M DTT,  1 µl of RNasin RNase Inhibitor (Promega), and 1 µl of 
Superscript III RNase H Reverse transcriptase (Invitrogen; 200U/µl) were added to make a total 
reaction volume of 20 µl. The reaction was incubated at 55oC for 1 hour and the cDNA product 
was subsequently used for PCR amplification. The 50 µl PCR reaction contained: 2 µl of cDNA 
template, 1 µl of 200 ng/µl forward and reverse primers (5’CGC ATA CGT AGC CTT CCG 
CGC GTG G 3’ and 5’ GTG GGG GCG GTC CGA GAC GC 3’; recognizing nt 1204-1229 and 
3877-3897, respectively), 4 µl of 2.5 mM dNTP’s, 25 µl of GC buffer (Takara), and 0.5 µl of 
Ex-Taq DNA polymerase (Takara; 5U/µl). The PCR protocol was as follows: 25 cycles of 96oC 
for 1 min, 65oC for 30 sec, and 72oC for 2 min followed by and incubation at 72oC for 10 min. 
The PCR product was gel purified (0.7% agarose) using a Qiagen gel extraction kit. The PCR 
product was sequenced by the GSU Core Facility. 
Analysis of PRR mutant RNA and DNA synthesis 
 Mutations in motifs 1, 2, and 1+2 were introduced into the Robo502-903 infectious clone 
that yields viruses which express P150 with an HA epitope tag. Mutations were done with 
mutagenic primers for motifs 1 and 2 (shown earlier) using an asymmetric 3 round PCR protocol 
as described previously [22]. These manipulations were done by Dr. Wen-Pin Tzeng. 
 Northern blot analysis of viral genomic and subgenomic RNA produced by wild type and 
mutant infectious clones was performed as described previously [23]; this analysis was 
performed by Dr Wen-Pin Tzeng. RNA was extracted from cells transfected with wild type and 
mutant infectious clones using Tri-Reagent (Molecular Research Center, Inc) according to the 
manufacturer’s protocol. For Northern gel analysis, equivalent amounts of RNA were denatured 
with Glyoxal Sample Loading Dye (Ambion, Austin, TX) for 30 min at 55°C and placed on ice 
immediately. The denatured RNA was electrophoresed in a 1% agarose gel made in 
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NorthernMax-Gly Gel Preparation/Gel Running Buffer (Ambion). After electrophoresis, the 
RNAs were transferred to a nylon membrane (0.45-mm pore diameter; MSI, Magnagraph, 
Westboro, MA) by capillary action for 2 hours using NorthernMax Transfer Buffer (Ambion) as 
the transfer medium. After transfer, the nylon membrane was irradiated with a 254-nm UV 
Crosslinker Lamp (Fisher Scientific, Pittsburgh, PA). The membrane was heat-sealed in a plastic 
bag containing NorthernMax Prehyb/Hyb Buffer (Ambion) and prehybridized for 2 hours at 
65°C. Nick-translated VR-C-E2-E1 probe (0.5 to 1 mg), which encodes the viral structural ORF 
was radiolabeled by nick translation using a Nick Translation System Kit (Promega, Madison, 
WI) and 50 µCi of [α-32P]dCTP (3000 mCi/mmol; New England Nuclear, Boston, MA). Half of 
the nick-translated DNA probe was denatured in 50% formamide at 100°C for 5 min and added 
to the blot in Prehyb/Hyb Buffer and hybridization was allowed to proceed at 65°C overnight. 
After hybridization, the membrane was washed at room temperature once in Low-Stringency 
Wash Solution 1 (Ambion) for 10 min and twice in High-Stringency Wash Solution 2 (Ambion) 
for 15 min at 42°C. Washed membranes were wrapped in plastic wrap and exposed to Kodak X-
ray film at -70°C between two Cronex Lightning Plus intensifying screens. 
Vero cells transfected with the wild type and mutant Robo502 constructs were also 
analyzed for P150 expression at 6 hours and 3 days post-transfection. Briefly, cells were 
harvested 6 hours and 3 days post-transfection using RIPA buffer (10 mM Tris-HCl pH 7.4, 150 
mM NaCl, 3 mM EDTA, 1% Triton X-100, 0.1% SDS, and 0.5% DOC). An equal volume of the 
post-nuclear fraction from wild type and mutant construct transfected lysates was mixed with 2X 
SDS loading buffer (100 mM Tris-HCl pH6.8, 20 mM dithiothreitol, 4% SDS, 0.2% 
bromophenol blue, and 20% glycerol) and resolved by electrophoresis on 6% SDS 
polyacrylamide gels (6% acrylamide, 0.38 M Tris pH 8.8, 0.1% SDS, 0.1% ammonium 
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persulfate). Proteins were transferred onto nitrocellulose membrane (Whatman) using 1X 
transfer buffer (100 ml 10X transfer buffer [250 mM Tris, 1.92M glycine], 200 ml 100% 
methanol, and 700 ml deionized water) at 100V for 1 hour in a mini-Protean II apparatus 
(Biorad). Following transfer, the membranes were blocked overnight with 5% non-fat milk 
powder in TBS (20 mM Tris-HCl, pH 7.5 and 175 mM NaCl). The blot was probed with mouse 
anti-HA monoclonal antibody (Roche) (1:1000 dilution) in antibody dilution buffer (1% non-fat 
milk powder, 0.02% sodium nitrate in TBS buffer [20 mM Tris-HCl, pH 7.5 and 175 mM 
NaCl]). After addition of primary antibodies, membrane was washed three times for 10 minutes 
each with 0.05% T-TBS (0.05% Tween-20 sorbitol in 1X TBS). Secondary anti-mouse antibody 
(Promega) conjugated with alkaline phosphatase, diluted in antibody dilution buffer (1:7500) 
was used to detect the presence of HA epitope tagged P150. Once again, membrane was washed 
3 times for 10 minutes each with 0.05% T-TBS and bound antibodies were detected with a 
BCIP/NBT (Roche) colorimetric assay.    
Transfection with pEBG constructs and identification of interacting cell proteins 
Sixty mm dishes of confluent 293-T cells were transfected with pEBG constructs using 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s protocol. Briefly, each plate 
was transfected with 5-10 µg of DNA and the transfection mixture was left on the cells for at 
least 4 hours before being replaced with Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) and penicillin-streptomycin (100 µg/ml). 
Three days post-transfection, the cells were washed twice with lysis wash buffer (1% Nonidet P-
40, 150 mM NaCl, 50 mM Tris-HCl pH 7.4, 2 mM EDTA and 150 mM sodium salicylate) and 
lysed with 1% NP40 buffer (1% NP40, 150 mM NaCl, 50 mM Tris-HCl pH 7.4 and 2 mM 
EDTA) and GST fusion proteins were isolated from the lysate using gluthathione sepharose 4B 
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beads (Amersham Pharmacia Biotech. Inc). Briefly, 0.5 ml gluthathione sepharose 4B beads 
(GST beads) were prewashed with 5 ml of phosphate buffered saline (PBS) containing 0.1% 
Triton X-100, collected by low speed centrifugation and resuspended in final volume of 5 ml 
PBS containing 0.1% Triton X-100. Before incubation of transfected cell lysates with the GST 
beads, the lysates was precleared with an equal volume of unconjugated sepharose beads 
(Sigma).  Following the preclearing step, 0.5 ml gluthathione beads were incubated with 5 ml of 
lysate for 3 hours at 4oC, after which the beads were washed seven times with lysis buffer (1% 
NP40, 150 mM NaCl, 50 mM Tris-HCl pH 7.4 and 2 mM EDTA), and adherent proteins were 
eluted with 2X SDS gel loading buffer (50 mM Tris-HCl, pH 6.8, 100 mM DTT, 2% SDS, 0.1% 
bromophenol blue and 10% glycerol). The proteins were resolved by 6% or 10% SDS-PAGE 
and proteins were visualized by GelCode blue staining reagent (Piercenet). Proteins of interest 
(ie. those that bound to GST-PRR/RUB but not GST-PRR/RUB MUT1+2 or the GST control) 
were excised with a scalpel and sent for trypsin digestion and mass-spectometry analysis to the 
facility at the Morehouse School of Medicine or the Scripps Institute (TSRI Center for Mass 
Spectrometry). Protein plugs were maintained in 4oC until transferred to these facilities. 
Construction of hemagglutinin (HA) and c-myc epitope tagged p32 protein 
The simian p32 gene in a pCB6 [24] vector was kindly provided by Dr. Tom Hobman 
(University of Alberta). Two p32 constructs were made, one, with HA and c-myc epitope tags on 
the N- and C- termini, respectively, and the other with a c-myc epitope on the C-terminus. The 
PCR primers used to create the first construct were 5’ CGA GCT AGC CCA TGT ACC CAT 
ACG ACG TCC CAG ACT ACG CTA TGC TAC CTC TGC TGC GCT GC 3’ (forward primer) 
and 5’ CGA GAA TTC CTA CAG ATC TTC TTC AGA AAT AAG TTT TTG TTC CTG GCT 
CTT GAC AAA ACT C 3’ (reverse primer) and to create the second construct were  5’ CTA 
80 
GCT AGC CCA TGC TAC CTC TGC TGC GCT GCG 3’ (forward primer) and 5’ CGA GAA 
TTC CTA CAG ATC TTC TTC AGA AAT AAG TTT TTG TTC CTG GCT CTT GAC AAA 
ACT C 3’ (reverse primer). Nhe I and Eco RI restriction sites (underlined) were introduced for 
the forward and reverse primers, respectively. Fifty µl PCR reactions contained 1 µl of pCBP6-
p32 DNA template, 1 µl each of 200 ng/µl forward and reverse primers,  4 µl of 2.5 mM dNTPs, 
10X buffer (Takara), and 0.5 µl of Ex-Taq DNA polymerase(Takara; 5U/µl). The PCR protocol 
was as follows: 25 cycles of 96oC for 1 min, 65oC for 30 sec, and 72oC for 1 min followed by an 
incubation at 72oC for 10 min. The PCR product was gel purified (0.7% agarose) using a Qiagen 
gel extraction kit. The PCR product was sequenced by the GSU Core Facility. The PCR products 
were digested with Nhe I and EcoR I, gel purified (Qiagen gel purification kit), and ligated into 
the pcDNA expression vector (Invitrogen) digested with the same enzymes.  The resulting 
constructs were named “pcDNA-HA-p32-myc” and pcDNA-p32-myc”, respectively. 
Immunoprecipitation and Western blot analysis 
Vero cells infected with Robo502-912 (with FLAG tagged P150 as described in the first 
Specific Aim) and transfected with pcDNA-HA-p32-myc were lysed with RIPA buffer (10 mM 
Tris-HCl pH 7.4, 150 mM NaCl, 3 mM EDTA, 1% Triton X-100, 0.1% SDS, and 0.5% DOC in 
the presence of 1X mini complete protease inhibitor [Roche]).  Another set of co-transfections 
was done to investigate the interaction of p32 with P150 without the presence of the RUBV 
capsid protein. To this end, a plasmid expressing HA-tagged P150 (CMV-P150-HA; provided by 
Dr. Wen-Pin Tzeng) was employed to transfect Vero cells either alone or with pcDNA-p32-
cmyc. Two days post-transfection, cells were harvested and 250 µl of lysate was used for 
immunoprecipitation studies. Briefly, 1 µl of mouse anti-HA, anti-c-myc monoclonal antibody 
(Roche) or rabbit anti-C1QBP polyclonal antibody (CeMines) was added as appropriate. Lysate 
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was incubated with the appropriate antibodies for 2 hours at 4oC. Thirty µl of agarose A beads 
(Roche) were added to the mixture and incubated for an additional hour.  The beads were washed 
five times with lysis wash buffer (10 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.5% Triton X-100, 
0.5% DOC, and 3 mM EDTA) and proteins were eluted by boiling with 60 µl 2X SDS gel-
loading buffer (100 mM Tris-HCl pH6.8, 20 mM dithiothreitol, 4% SDS, 0.2% bromophenol 
blue, and 20% glycerol). Samples were resolved using 6% or 10% SDS-PAGE (6% or 10% 
acrylamide, 0.38 M Tris pH 8.8, 0.1% SDS, 0.1% ammonium persulfate). Proteins were 
transferred onto nitrocellulose membrane (Whatman) using 1X transfer buffer (100 ml 10X 
transfer buffer [250 mM Tris, 1.92M glycine], 200ml 100% methanol, and 700 ml deionized 
water) at 100V for 1 hour in a mini-Protean II apparatus (Biorad). Following transfer, the 
membranes were blocked overnight with 5% non-fat milk powder in TBS (20 mM Tris-HCl, pH 
7.5 and 175 mM NaCl). The blot was probed with mouse anti-HA monoclonal antibody (Roche) 
(1:1000 dilution), mouse anti-FLAG monoclonal (Sigma)(1:1000 dilution) or rabbit anti-p32 
antibody (CeMines)(1:1000) in antibody dilution buffer (1% non-fat milk powder, 0.02% sodium 
nitrate in TBS buffer [20 mM Tris-HCl, pH 7.5 and 175 mM NaCl]). After addition of primary 
antibodies, membrane was washed three times for 10 minutes each with 0.05% T-TBS (0.05% 
Tween-20 sorbitol in 1X TBS). Secondary anti-mouse antibody (Promega) conjugated with 
alkaline phosphatase, diluted in antibody dilution buffer (1:7500) was used to detect the presence 
of HA epitope tagged P150. Once again, membrane was washed 3 times for 10 minutes each 
with 0.05% T-TBS and bound antibodies were detected with a BCIP/NBT (Roche) colorimetric 
assay.    
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Immunofluorescence assay  
The intracellular localization of HA-tagged P150 and c-myc-tagged p32 was analyzed by 
immunofluorescence (IFA) as described previously [25]. Briefly, Vero cells were plated on 18 
mm glass coverslips placed in 35 mm plates (1:25 ml dilution). Cells were transfected with 
pcDNA-p32-myc and co-transfected with CMV-P150-HA or infected with Robo502-930 
(expressing an HA-tagged P150). Forty eight hours post transfection, the cells were fixed with 
4% paraformaldehyde in PBS for 30 min at 4oC and permeabilized with PBS-0.25% saponin for 
10 min at room temperature. The coverslips were removed from the culture dishes, washed again 
with PBS, and blocked by incubation with PBS, 2% BSA, 0.25% saponin for 30 min at room 
temperature. Primary antibodies diluted 1:500 in PBS, 0.1% BSA, 0.25% saponin were placed 
on the coverslip and incubated for 1 hour at room temperature. The primary antibodies used were 
mouse anti-HA monoclonal antibody (Roche), mouse anti-c-myc monoclonal antibody (Roche) 
or rabbit anti-C1QBP (CeMines) polyclonal antibody (all in 1:500 dilution). After washing three 
times in PBS, secondary mouse anti-FITC antibody and rabbit anti-TRITC antibody diluted 
1:1000 in PBS, 0.1% BSA, 0.25% saponin were added and incubated for 30 minutes at room 
temperature. 1:1000 dilution of Hoechst was added in the reaction during the last 2 minutes of 
incubation. Following washing with PBS, the coverslips were mounted on glass slides using 
ProLong gold anti-fade reagent (Molecular Probes/Invitrogen). The cells were visualized using a 
Zeiss Axioplan 2 imaging system at 100X magnification.  
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RUBV replication in cells overexpressing p32 
 Vero cells were either mock transfected or transfected with pcDNA-p32-myc as 
described above.   One day post-transfection, both cultures were infected with wt RUBV at an 
MOI of 1. The cells were examined daily by microscopy for development of CPE and the 
medium was collected each day through four days post-infection and subsequently titered by 
plaque assay [21]. 
Results 
Effect of mutagenesis of the putative SH3 binding domain in P150 on virus replication 
Fig. 3.1A shows a schematic diagram of the domains within RUBV P150, including the 
proline rich region (PRR) of interest.  The PRR is located between amino acid residues 716 
through 782 of P150.  This region is also known as the hypervariable region or, HVR as it is the 
most variable region of the RUBV genome among natural RUBV isolates [26]. Analysis of the 
PRR using ScanProsite software (Expasy Proteomics Server) led to the identification of 3 
putative Class II SH3 binding motifs with the consensus amino acid sequences “P-x-x-P-x-R”. 
Fig. 3.1B shows the sequence of the PRR with the three putative SH3 binding motifs in color. 
These putative SH3 binding motifs are referred to as motifs 1, 2 and 3, from the N- to C-
terminus of the PRR respectively.  An alignment of sequences of the PRR from viruses of 7 
genotypes showed that all three motifs were highly conserved (Fig. 3.2), with the exception of 
the Anam5_KOR96 strain of RUBV that had a serine instead of a proline in motif 1 (S-x-x-P-x-
R instead of P-x-x-P-x-R). However, this strain of virus had the ability to replicate to levels that 
were similar to other strains of virus with conserved PxxPxR sequences (personal data 
communication). The presence of conserved PxxPxR sequences in motif 2 of the 
Anam5_KOR96 strain may possibly compensate for the lack of such conservation in motif 1. 
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This may also help explain the importance of repeated PxxPxR sequences being present in one 
small region of the proline rich domain. 
To analyze the importance of the PxxPxR motifs in RUBV replication, proline to 
alanines mutations were made in the critical proline residues of each motif, i.e. P-x-x-P-x-R to 
A-x-x-A-x-R, in the RUBV infectious cDNA clone, Robo502 [19]. Mutations in the individual 
motifs were named Mut1-Robo502, Mut2-Robo502 and Mut3-Robo502. In addition, 
combination mutations were made in motifs 1 and 2 as well as in all three motifs and these 
constructs were named Mut1+2-Robo502 and Mut-X-Robo502, respectively. In vitro transcripts 
synthesized from these constructs were used to transfect Vero cells and the transfected cell 
medium was collected seven days post-transfection. Cytopathic effect (CPE) is usually observed 
in cells transfected with transcripts from wt Robo502 at three days post-transfection. Plaque 
assays done on medium harvested from the Mut1-, Mut2-, and Mut3-Robo502 transfected cells 
(passage 0 or P0) revealed that the Mut3-Robo502 transcripts produced a titer and plaque 
morphology that were the same as for wt Robo502 transcripts. Also, CPE were observed on day 
3 post-transfection with wt and Mut3-Robo502 transcripts. However, cells transfected with 
Mut1- and Mut2-Robo502 transcripts yielded lower virus titers (1-4x104 pfu/ml) and a small 
plaque morphology (see Fig 3.3). We further investigated the relative importance of these first 
two domains with the combination mutants.  Mut 1+2-Robo502 transcripts produced low virus 
titers (1x104 pfu/ml) with a small plaque morphology, although CPE were observed on day 3 
post-transfection. Mut-X-Robo502 failed to show evidence of replication.  
P0 medium was subsequently passaged once in Vero cells. As shown in Fig 3.4, the P1 
titer and plaque morphology as well as the development of CPE were similar for all five mutants 
and wild type virus. These data suggested that reversion of the mutations in the SH3 binding 
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domain may have occurred and we investigated this possibility by sequencing the virus from 
infected cells.  The results are shown in Table 3.1. The mutant Motif 1 present in the Mut1-, 
Mut1+2, and MutX-Robo502 constructs reverted to the wt sequence and the mutant Motif 2 
present in the Mut2- and MutX-Robo502 constructs reverted to the wt sequence.  Interestingly, 
the mutant Motif 2 in the Mut1+2-Robo502 construct did not revert. The mutant Motif 3 in 
either Mut3- or MutX-Robo502 did not revert as expected from the wt phenotype exhibited by 
the Mut3-Robo502 construct.  
 We next wanted to see if the Motif 1 or Motif 2 mutations affected synthesis of either 
P150 or viral RNA.  Fig. 3.5 A and B show Western blots to detect P150 at 6 hours and 3 days 
post-transfection. P150 levels at 6 hours represents translation from input transcripts (a control 
indicative that the construct is functional) and 3 days translation is from replicated transcripts. 
One of the two Mut1+2-Robo502 clones that were tested was nonfunctional. This is one of the 
reasons for the 6 hr post-transfection screening. As for the other Robo-502 mutant clones, little 
difference between wt and either the single mutants or double mutant was detected. The 
difference that was noted was that the translation levels of P150 from the Mut1-Robo502 clones 
were slightly lower than from the wt construct. However, levels of P150 translation for the wt 
and all the mutant clones were similar 3 days post transfection. A Northern blot shown in Fig 
3.5C shows that levels of RNA, 3 days post transfection for the single or the double mutations, 
were similar in levels to the wt. We cannot conclude that the levels of genomic and subgenomic 
RNA were not affected by the mutations because reversions seem to occur rapidly and could 
have accounted for the majority of RNA present. 
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Identification of host proteins that bind to Motifs 1 and 2 in the P150 PRR 
 We next wanted to investigate the host proteins that bind to the PRR within P150.  Since 
mutations of Motifs 1 and 2 suppressed virus yield and also reverted to wt sequences, we 
concentrated on these motifs.  To do so, we made a GST fusion expression construct in which 
GST was fused to the PRR. Fig. 3.6 shows a schematic diagram of the wild type construct, GST-
PRR/RUB. Another construct containing mutations in both motifs 1 and 2, GST-PRR/RUB 
Mut1+2 was also constructed. Fig. 3.7 shows the strategy employed to identify the host factors 
that specifically bound to the PRR.  Basically, proteins binding to the wt GST-PRR/RUB, but 
not the GST-PRR/RUB Mut1+2 with mutations in motifs 1 and 2 were considered as candidates 
(see Fig.3.8).  When this strategy was employed, a total of 4 putative host proteins were 
identified, termed PRR-1, PRR-2, PRR-3, and PRR-4 (Fig. 3.8). The first protein that was 
identified, PRR-4, (by Dr Powell of Morehouse School of Medicine) is p32 (score:46.11), which 
was previously shown to bind to the RUBV capsid protein and for which constructs and reagents 
were readily available. The other three proteins that were identified by the Mass Spec facility at 
the Scripps Research Institute were PRR-1: human Mdn1 protein (Q9NU22), PRR-2: Gcn1L 
protein (Q92616), and PRR-3: nucleopore complex protein Nup205 (Q92621). More than 2 
peptides were identified at 95% confidence for all three of these proteins. There are no 
commercially available reagents for any of these three proteins, whose functions will be 
discussed later. Therefore, further characterization was confined to p32.  As shown in Fig. 3.9, a 
Western blot probed with anti-p32 antibodies confirmed the binding of p32 to GST-PRR/RUB 
(wt) but not GST-PRR/RUB-MUT 1+2 or the GST control.   
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Confirmation of the binding of host protein p32 to RUBV P150  
To confirm that p32 binds to P150 as well as the GST-PRR/RUB fusion protein, a 
plasmid construct expressing an HA tagged P150 was used to transfect Vero cells.  
Immunoprecipitation was then performed with either anti-HA antibody, a control for pull-down 
of expressed HA tagged P150, or anti-p32 antibody, to detect a P150-p32 interaction.  Fig. 3.10 
shows a Western blot of immunoprecipitated proteins probed with anti-HA antibody to detect 
HA-tagged P150.  Lane 3 shows the positive control while Lane 4 demonstrates that P150 was 
co-immunoprecipitated with p32. This result indicated that the binding of P150 was authentic.   
We next explored the interaction between P150 and expressed p32.  For this purpose, two 
p32 expression constructs were generated, one tagged on its N-terminus with an HA epitope and 
on its C-terminus with a c-myc epitope (pcDNA-HA-p32-myc) and one tagged only on its C-
terminus with the c-myc epitope (pcDNA-p32-myc).  Vero cells were transfected with pcDNA-
HA-p32-myc and co-infected with Robo502-912, which carries a FLAG epitope on P150 (this 
infectious clone was used in Specific Aim 1).  The Fig. 3.11 Western blot shows that FLAG-
tagged P150 expressed from virus co-immunoprecipitated with the plasmid expressed HA-p32-
myc.  In an experiment that employed the expressed p32-myc in cells co-transfected with HA-
p32-myc and CMV-P150-HA plasmid, reciprocal immunoprecipitation was demonstrated (Fig. 
3.12).  Specifically, HA-tagged P150 was co-immunoprecipitated by c-myc antibodies which 
react with p32-myc (Panel A) while c-myc-tagged p32 was co-immunoprecipitated by anti HA 
antibodies which react with HA-tagged P150.  An additional protein band present above p32-c-
myc in lane 4, Panel B (Fig. 3.12), may represent a modified p32 protein. 
 
88 
Interaction between the two proteins was also explored by immunofluorescence.  As 
shown in Fig. 3.13, Panel B, plasmid expressed HA-tagged P150 (red) co-localized with 
expressed p32 (green) in perinuclear foci.  The same observation was made when cells were 
infected with Robo502/912 which expresses an HA-tagged P150 (Fig 3.13, Panel A) and thus 
interaction occurs whether P150 is expressed in a plasmid or virus context.   
 Finally, in light of our earlier results that mutations in motifs 1 and 2 in the GST-
PRR/RUB fusion abolished the binding of p32, the finding that led to identification of p32 as a 
P150 pairing partner, we introduced the same motif 1 and 2 mutations into the CMV-P150 
expression contruct. Vero cells were co-transfected with pcDNA-p32-myc and either CMV-P150 
or CMV-P150-MUT1+2 vector DNA. As shown in Fig. 3.14, anti-c-myc antibody co-
precipitated P150 expressed by CMV-P150 (Lane 4) but not mutant P150 expressed by CMV-
P150-MUT1+2 (Lane 6). Thus, P150-p32 binding is mediated by the PRR region of P150.   
Investigation of the function of p32 in the RUBV life cycle 
 Evidence obtained with virus that had mutations in the PxxPxR motifs in the PRR 
indicated that while this region was not necessary for virus RNA synthesis and concomitant 
protein production, these mutations suppressed virus titers and revertants were rapidly generated.  
We thus wanted to look at the physiological relevance of the p32-P150 interaction as means of 
further studying this phenotype.  Previous attempts in our lab to knockdown p32 using siRNA 
were unsuccessful (H. Mousa, unpublished observations) and another lab also did not have 
success (T. Hobman, personal communication).  We therefore tested the effect of overexpression 
of p32 on RUBV replication [27]. Vero cells transfected with pcDNA-p32-myc were co-infected 
with RUBV. Approximately 80% of cells were successfully transfected (data not shown). As 
shown in Fig. 3.15, p32-myc expression was maintained through 4 days post-transfection, 
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whether the cells were infected or not, and the localization of expressed p32-myc by 
immunofluorescence (Fig. 3.16) was comparable to endogenous p32 as shown in Fig. 3.13. 
However, as shown in Table 3.2 the increased levels of p32 in the transfected cells mildly 
increased the levels of virus replication in the first two days post infection, compared to mock-
transfected cells. These data taken together would suggest that p32 may be involved in the ability 
of the virus to replicate because the presence of an increased amount of host factor did lead to an 
increase in the amount of virus production, especially early times of infection.  
Discussion 
 In this study, we investigated the PRR region of RUBV P150, spanning from amino acids 
716 to 782, that contained a putative SH3 binding domain. We wanted to know if the three P-X-
X-P-X-R consensus Class II SH3 binding motifs of interest that were predicted in this region and 
that were conserved despite the variability of the region among viral isolates, were of any 
consequence to the RUBV life cycle. In order to do this, we made proline to alanine mutations, 
ie P-X-X-P-X-R to A-X-X-A-X-R, in the three putative SH3 binding motifs (we called these 
Motifs 1, 2 and 3) in the RUBV infectious clone, Robo502.  After transfection of Vero cells, it 
was apparent that the Motif 1 and 2 mutants negatively affected virus replication.  First, the cells 
transfected with these mutants did not exhibit CPE. Usually, CPE occurs on day 3 following 
transfection with wt Robo502.  Secondly, viral RNA mutated in either of the first two motifs 
produced virus titers that were at least 2 logs lower compared to wild type RNA. Thirdly, the 
Motif 1 and 2 mutants produced small plaque morphology. In contrast, mutations made in the 
third predicted SH3 binding motif yielded a phenotype similar to wild type, indicating that this 
predicted motif was not of importance to the replication of the virus.  A double mutant of motifs 
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1 and 2 exhibited a phenotype similar to the individual motif 1 and 2 mutants while a triple 
mutant of all three motifs produced neither CPE nor plaques following transfection. 
 Culture medium from transfection plates was passaged to see if revertants would arise. 
P1 medium from infections with viruses with mutations in motif 1, motif 2, or motifs 1+2 
displayed a similar titer and plaque morphology as did wild type virus. Virus with the triple 
mutation also displayed a wild type phenotype after the first passage. These observations 
prompted us to analyze the sequences of the passage 1 viruses. As expected, we found that 
individual mutations made in motifs 1 and 2 had reverted to the wild type sequence as had both 
these motifs in the triple mutant. In the double motif 1+2 mutant, only motif 1 reverted to wild 
type. However, mutations made in motif 3, either in the individual mutant or in the triple mutant, 
did not revert to the wild type sequence. These data strongly suggested that the motifs 1 and 2 of 
the predicted SH3 binding domain were under positive selection pressure and were important for 
the virus life cycle.  
 Next, we looked at translation of P150 following transfection to see if the mutations in 
the region of interest affected levels of protein translation using Western blot analysis of lysates 
collected 6 hours and 3 days post-transfection with the individual motif 1 or motif 2 mutants or 
the double mutant.  The first time point represents translation of the input transcript while the 
second time point represents translation from replicated transcripts. As mentioned in the results, 
levels of P150 translation of viral RNA with mutation in motif 1 was lower compared to wt at 6 
hours post-transfection. However, the result of the 3 day time point indicated wt-level replication 
for the genome RNA. Also, Northern blot analyses of the intracellular genomic and subgenomic 
RNA levels showed no differences between the mutants and wt. These data do not necessarily 
indicate that the mutations had no effect on the production of subgenomic or genomic RNA. As 
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revertants seem to occur rapidly, it is possible that by 3 days post-transfection, the majority of 
the genomic and subgenomic RNA accumulated were apparently reverted (wt). To accurately 
evaluate the effects of mutations on levels of viral genomic and subgenomic RNA production, 
the experiment has to be approached in two ways. One way is to look at RNA levels at times that 
are earlier than 3 days post-transfection, having an appropriate control for the decay of input 
transfected infectious clone RNA. Secondly, instead of point mutations, proline rich sequences 
of interest could be deleted to avoid the occurrence of revertants. Such experiments would 
provide an accurate assessment of the effect of the PxxPxR sequences of P150 RUBV on virus 
replication.   
 The role of proline rich domains in the proteins of other viruses has been associated with 
virus maturation and release [28, 29] as well as pathogenicity [17]. The C-terminus of the Gag 
protein of HIV, for example, has a proline rich region (PxxP motif), called the P6 domain that 
has been shown to play an important role in virus budding and release [30]. Mutations made in 
this region resulted in a 20 fold decrease in virus production. The process of virus budding and 
release is known to occur through interaction of virus components with a variety of host proteins 
mediated by PxxP motifs. A protein called Tsg101 is a host protein involved in the sorting of 
proteins via the endosomal sorting complex required for transport (ESCRT) [31]. Binding of 
Tsg101 to the PxxP (Pro-Thr-Ala-Pro) domain of HIV-1 Gag protein has been shown to be 
critical for the proteolytic processing of Gag and virus particle release [32, 33]. The Ebola virus 
Vp40 matrix protein (EbVp40) was also shown to contain a PxxP motif that is important for 
virus particle egress through interaction with Tsg101 [34]. We know from previous studies that 
RUBV P150 interacts with the capsid structural protein. It is possible that the PRR domain 
within P150 mediates the interaction with capsid protein via host cellular factors (e.g. p32 binds 
92 
to both) so that virus assembly and release can occur. The disruption of this interaction by 
mutagenesis of the P150 PxxP motifs could have caused the observed decrease in virus release. 
Alternatively, a host factor binding to P150 may be important in transport of the newly replicated 
virus RNA to the site of virion assembly. 
Viral SH3 binding domains are also important in regulating signaling pathways that 
promote virus replication.  For example, in a recent study involving influenza A virus, SH3 
binding domains were found in the NS1 nonstructural protein [18], an important virulence factor. 
An association of the NS1 SH3 binding domain with Crk/CrkL proteins was found. These 
proteins contain SH3 domains and have been implicated in a variety of signaling pathways, 
including the PI3K pathway involved in cell survival. In this study, the researchers found 
through mutagenesis of the NS1 region responsible for binding to the Crk/CrkL proteins that 
interferon suppression mediated by NS1 was not affected, but rather PI3K signaling was not 
enhanced. Activation of PI3K signaling had been previously shown to enhance influenza A virus 
replication and decrease apoptosis in infected cells [15]. Therefore, this study provides a 
mechanism that is mediated through the SH3 binding domain of NS1 protein that is important for 
the replicative capacity of the virus and similar interactions between P150 and signaling 
pathways could be important in the RUBV life cycle.   
Aside from interaction with host cellular factors that affect virus maturation via assembly 
and release or cell signaling pathways that promote virus replication, it has been extensively 
shown that PxxP motifs and their interaction with SH3 domains play a role in the development 
of virus pathogenesis. The HIV Nef protein is one such example of a virus protein that contains a 
PxxP consensus sequence. Nef is important for several functions. Firstly, it is important for 
enhancing infectivity of virus particles [14, 35, 36]. Secondly, it has a role in the regulation of 
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CD4 and MHC I expression on the plasma membrane [37, 38]. Thirdly, it has been shown to be 
involved in cellular signaling [39]. Nef protein is important for the pathogenesis of the virus as it 
is required for the development of AIDS in humans and rhesus macaques [40, 41]. In one study 
on the Nef PxxP consensus sequence, it was found that it binds to a member of the Src kinase 
family, Hck protein, a form of tyrosine kinase which is involved in cellular signaling [13, 42]. 
The interaction of Nef protein with Hck was found to be important for the infectivity of HIV-1. 
Hepatitis C virus (HCV) nonstructural protein NS5A also has class II PxxP consensus 
sequences in its C-terminus. NS5A is an important virus protein involved in IFN-α resistance 
[43, 44] and replication in general [45-47]. The PxxP sequence of NS5A was shown to bind 
Amphiphysin II (Bin1) in two different studies [48, 49]. This interaction was mediated through 
an SH3 domain present in the C-terminus of the Bin1 protein. Bin1 is a nucleocytoplasmic c-
myc interacting protein associated with apoptosis [50] and clathrin mediated endocytosis [51]. 
According to these studies, mutations in the SH3 binding domain of NS5A resulted in a virus 
that was not infectious in chimpanzees and also not able to overcome Bin1 induced apoptosis. 
These data point to the importance of this particular SH3 binding domain in viral pathogenesis. 
The importance of the viral SH3 binding domains in pathogenesis of a virus was also 
shown in studies of the PxxP motif of the gp30 protein of bovine leukemia virus (BLV) [17]. In 
this study, infection of sheep with viruses having mutations in the PxxP motif of the BLV gp30 
transmembrane protein did not lead to tumorigenesis while sheep infected with the wild type 
virus died of leukemia and lymphoma. Although all of the animals seroconverted at 
approximately the same time, only those transfected with the wild type virus developed tumors, 
revealing the importance of the SH3 binding domain in the development of tumors in animals 
infected with this virus. Data from other viruses suggest that there is a possibility that RUB P150 
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through interaction with host factors via its SH3 domain is important for the development of 
pathogenesis of the virus. However, the lack of an animal model for RUB would make it difficult 
to further study this hypothesis. 
 Since we had shown that the predicted SH3 binding domains 1 and 2 of RUB P150 are of 
importance to the virus life cycle, we next wanted to identify the potential binding partners of 
these domains. Binding experiments using the PRR of P150 fused to GST as bait led to 
identification of four putative host cellular interacting proteins, namely the p32 protein (gC1qR), 
human Mdn1 protein, Gcn1L protein and nucleopore complex protein Nup205. The human 
Mdn1 protein is a homolog of the yeast Rea1 protein that is involved in ribosome biogenesis 
[52], Gcn1L protein has protein binding and ribosome binding domains that are involved in 
regulation of translation [53] and the Nup205 protein is part of the nuclear pore complex and, 
like other members of the nuclear pore complex, is involved in regulating permeability of the 
nuclear membrane [54]. Interestingly, studies have shown that some RNA viruses target 
members of the nuclear pore complex to disrupt normal trafficking of host RNA and proteins 
[55], a mechanism that probably targets host cell protein synthesis.  In this regard, RUBV does 
not exhibit a marked shutdown of either cell RNA or protein synthesis [56]. The interaction of 
these three host factors with P150 was not investigated as there were no commercially available 
reagents to do so. We decided to investigate the interaction of p32 with RUB P150 as there was 
precedence for the binding of this protein to RUB capsid protein [24, 57] as well as to proteins of 
other viruses [58-60]. It was therefore quite plausible that the p32 host protein in conjunction 
with both P150 and capsid (both p32 interacting partners) is involved in the regulation of the 
viral life cycle. Furthermore, reagents for p32 were commercially available to facilitate our 
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studies.  These reagents were first used to confirm that p32 bound to wt GST-PRR/RUBV, but 
not GST-PRR/RUV MUT 1+2.   
 We next wanted to ensure that p32 bound to the complete P150 protein and did so by 
expressing P150 in Vero cells and showing that it was co-immunoprecipitated by anti-p32 
antibodies. Finally, an immunofluorescence assay using anti-p32 antibodies showed co-
localization of P150, either in virus-infected cells or cells transfected with the P150 expression 
construct, with endogenous p32. In virus infected cells, the foci of P150 colocalized with p32, 
but there were also cytoplasmic punctae of p32 not associated with P150.  In P150-transfected 
cells, P150 fibers were formed and colocalization of p32 with these fibers was observed. 
 For subsequent experiments, we expressed p32 protein from a pcDNA expression vector 
with epitopes at the N and/or C termini of the protein. The construct design was based on the 
precursor form of p32 (282 amino acids in length) that had 73 amino acids at the N-terminus 
containing a mitochondrial targeting sequence [61]. We designed two constructs, one that had a 
HA epitope at the N-terminus and a c-myc epitope at its C-terminus and one that only had the c-
myc epitope at the C-terminus. Anti-HA antibodies were used to co-immunoprecipitate P150 in 
lysates of virus-infected cells co-transfected with the HA-p32-myc construct. However, the 
amount of P150 that was pulled down was low. Three factors could have contributed to this 
observation. Firstly, there were low levels of RUB P150 present in these cells because it was 
expressed from the virus; secondly, an HA epitope at the N terminus of p32 could be masking 
the interaction site for RUB P150; and thirdly, the retargeting of p32 to a different site in the 
cytoplasm because of the presence of a tag on the N terminus that contains the mitochondrial 
targeting signal. P32 in this new site may not be easily accessible for the binding to RUB P150. 
The retargeting of p32 to a site other than its usual one due to the addition of an epitope tag at 
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the N-terminus was shown by a group of cell biologists in the UK [62]. Thus, we used C-
terminally c-myc-tagged p32 construct for the remainder of the experiments. 
Immunofluorescence assay of this construct showed localization that was comparable to the 
distribution of endogenous p32 as was described by other researchers [62, 63]. We first used the 
pcDNA-p32-myc construct to demonstrate reciprocal co-immunoprecipitation between p32 and 
P150 in cells co-transfected with CMV-P150 and pcDNA-p32-myc.   
 In order to try to understand the role that p32 is playing in the RUBV life cycle, we 
looked at the effects of p32 overexpression on virus titer based on an earlier report that 
overexpression of p32 in Vero cells enhanced RUBV replication [27]. In that study, researchers 
overexpressed p32 in Vero cells and looked at the levels of RUBV capsid protein as an 
indication of levels of infection because they were not able to measure production of virus by 
plaque assay. They found that cells overexpressing p32 had significantly higher levels (about 
75% higher that control cells not overexpressing p32) of RUBV capsid as evident through 
Western blot and IFA analysis. Their analysis was done 3 days post-infection. For our studies, 
Vero cells were first transfected with pcDNA-p32-myc and then infected the following day with 
RUBV. Culture medium was collected each day post-infection for four days and virus titer was 
determined. A mild increase (about ½ log) in viral titers were observed between Vero cells and 
pcDNA-p32-myc transfected cells, especially on days 1 and 2 post-infection. The expression of 
p32 over the duration of the experiment was further confirmed by Western blot. Based on our 
findings, we cannot make comparisons with the earlier report [27] because RUBV replication in 
that report was measured by accumulation of intracellular capsid protein, not plaque assay. 
While higher viral titers during the first 2 days of virus infection in cells overexpressing p32 
could be related to the finding that RUBV capsid is increased in amount, further studies need to 
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be done especially at earlier infection times, before we can draw those conclusions. Another 
observation that was made in infected cells overexpressing p32, was that CPE was somewhat 
stronger than in the RUBV-infected Vero cells.  RUBV-induced CPE in Vero cells is due to 
induction of apoptosis [64, 65] and a propidium iodide-based assay to detect apoptotic cells 
indicated an increase of sub-G0 phase cells in p32 transfected vs the untransfected Vero cell 
cultures infected with RUBV (data not shown).  It has been shown that p32 is associated with 
induction of apoptosis [66, 67].   
 Our results do not prove that the phenotype of viruses with mutations in Motifs 1 and 2 in 
the P150 PRR (ie. little effect on RNA synthesis or NSP expression, but reduced titer and rapid 
reversion) are due to abrogated binding of p32 and thus the function of p32 in the RUBV life 
cycle, if any, is not clear, but potential functions may be speculated on based on our findings and 
previous work on p32 and its association with other viruses.  The p32 protein is known by other 
names: gC1Qr (globular heads of the C1q protein receptor) and HABP (the hyaluronic acid-
binding protein). The diversity in the names of this protein are an indication of the multiple 
functions that this protein is thought to have. Historically, the p32 protein was isolated as part of 
the ASF/SF2 human splicing factor complex in the nucleus of HeLa cells [68]. In a later study 
[69], it was suggested that p32 regulated the activity of the ASF/SF2 complex by acting as an 
inhibitor to control RNA binding activity. This was shown to be achieved through inhibition of 
ASF/SF2 phosphorylation. In addition to its function in the nucleus, p32 was later shown to be a 
resident of the mitochondria [63] and in this study it was found that p32 was primarily a resident 
in mitochondria. Additionally, mutations of genes homologous to p32 in yeast showed that p32 
was involved in maintaining oxidative phosphorylation. Aside from this study, earlier work on 
p32 showed that it functioned as a phosphate translocator in mitochondria [70, 71]. Another 
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report that supports the localization of p32 in the mitochondria was one that showed the binding 
of mitochondrial precursor proteins to p32 [61]. These researchers showed that proteins destined 
for the mitochondria were bound to p32 through a mitochondrial signal sequence which allowed 
p32 to act as an import receptor. It was later shown that p32 does indeed contain a 73 amino acid 
mitochondrial targeting sequence at the N-terminus that is efficiently removed by proteolytic 
processing [63]. P32 was also identified as a potential binding partner for a variety of proteins 
that would have to bind p32 at the cell surface. Examples of some of these proteins are C1 
complement component protein, C1g [72], and other extracellular plasma proteins involved in 
coagulation such as kininogen [73], and factor XII [74]. All these findings suggests that p32 is a 
multifunctional protein. 
 The interaction of p32 with proteins from a variety of viruses, and even bacteria, has 
been documented. For instance, the interaction of p32 with the HIV Tat and EBV EBNA-1 
proteins was shown to be important for enhancement of transcriptional activity [58, 75]. 
Additionally, p32 was shown to bind to the HIV Rev protein [60], which facilitates nucleus to 
cytoplasm transport of unspliced HIV RNA, and also to the adenovirus core protein that 
potentially mediate the shuttling of adenoviral DNA into the nucleus [59, 76]. From these studies 
it seems that p32 is involved in two main kinds of function: RNA-related regulatory functions 
and shuttling of RNA. One interaction of particular interest to us is the interaction between p32 
and the RUBV capsid protein [24, 57]. This interaction was hypothesized to be involved in the 
reorganization and distribution of [25] mitochondria to cluster around CPVs, which is a unique 
hallmark of RUBV infection [25] . This reorganization of mitochondria was thought to perhaps 
serve as a source of energy for the RNA synthesis process. It was also hypothesized that the 
reorganization of mitochondria by capsid may facilitate the incorporation of cardiolipin into the 
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mature virion [77].  In addition, disruption of the p32 binding site on the capsid protein leads to 
decreased levels of virus production, as measured by plaque assay, and a specific decrease in the 
synthesis of the subgenomic RNA [57].  However, the binding sites that were mutated were two 
arginine clusters that have also been shown to bind the viral RNA.  The capsid protein is 
important in both modulating the ratio of genomic to subgenomic RNA [57] and in capsid 
formation and thus these capsid mutations could have affected these functions independent of 
binding p32.   
 As for the association of p32 with RUB P150, two possible functions that could be 
mediated by this interaction are virion assembly and virus pathogenesis.  Concerning virus 
assembly, P150 forms a fibrous network in cells [78] that could be involved in helping virus 
particle movement out of the infected cell and our data indicate that p32 is recruited to this 
network. As discussed earlier, a variety of host proteins found in the extracellular matrix have 
been shown to bind to p32. In a study that used immunogold electron microscopy to evaluate 
subcellular localization of p32 [79] in various culture cell lines, apart from detecting the 
presence of p32 in the mitochondria, this protein was also found on cell surface of pancreatic 
acinar cells. P32 was also found in zymogen granules, condensing vacuoles and endoplasmic 
reticulum. In another experiment that attempted to track the localization of p32 after attaching 
epitope tags to either the N or C termini of the protein, researchers made the observation that 
masking the mitochondrial targeting signal (MTS) redirected p32 either to the ER or to the cell 
surface [62]. They hypothesized that masking the N terminus MTS caused the redirection of the 
protein to these other locations in the cells, possibly explaining the ambiguity in the variety of 
locations that p32 is found. It is possible that the binding of p32 to both P150 and capsid protein 
could functionally be important during virus assembly. However, further studies have to be done 
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to test this hypothesis. One study that could be done is to look at the effect of P150 PxxP mutants 
on the localization of P150 and on the co-localization of P150 with p32. 
 Two recent studies suggests a role for p32 in reducing mitochondrial membrane potential 
and inducing apoptosis [66, 67]. Our previous studies have shown that P150 is the determinant of 
cytopathogenicity in Vero cells [21] and recent studies in our lab showed that RUB P150 alone 
can induce apoptosis. Interestingly, induction of apoptosis is suppressed in the presence of the 
capsid protein (unpublished data). It is therefore possible that the interaction of P150, capsid 
protein, and p32 modulates the induction of apoptosis in infected cells.    
 In conclusion, we found that mutations in the first 2 PxxPxR motifs of P150 led to a 2 log 
decrease in viral titers after passage 0. Additionally, the mutations in motifs 1 and 2 reverted to 
wt sequence by the first passage. As for the effects of mutations on levels of genomic and 
subgenomic RNA, we did not see significant differences 3 days post-transfection of wt and 
mutant viral RNA. However, with the rapid rate of reversion observed, genomic and subgenomic 
RNA levels should probably be analyzed at earlier times post-transfection. As for the studies 
involving host cellular factors that bind to the proline rich region, we confirmed the binding of 
cellular p32 to motifs 1 and 2 of P150. Overexpression of p32 in cells infected with RUBV led to 
½ log increase in viral titers at earlier times post-infection. Further studies need to be done to 
elucidate the actual role of p32 in the RUBV life cycle. In addition to p32, 3 other cellular 
proteins were identified, but further analyses of these interactions with P150 were not pursued. 
More host proteins may associate with the proline region of P150, but our technique of 
interacting protein detection led to the identification of host proteins that were present in higher 
abundance. 
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Figure 3.1A. RUBV genomic organization and  domains within the P150 nonstructural 
protein. 
A) Rubella virus genome organization showing the two ORFs and five nonstructural and 
structural proteins encoded by the virus. B) Domains present within the P150 nonstructural 
protein (1301aa): MT (methyl/guanylyltransferase), nt 230-439 (70aa); PPR (polyproline 
region), nt 2120-2440 (107aa); XD (X domain, adenosyl-ribose phosphatase), nt 2492-2998  
(169aa); NP (nonstructural protease), nt 3041-3940 (300aa). 
 
Figure 3.1B. Predicted consensus SH3 binding motifs within the P150 PRR. 
The sequence of the PRR within P150 (aa 716-782) is given.  Motifs 1 through 3 are predicted class 
II SH3 binding domains with PxxPxR consensus sequences.  
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Figure 3.2. Multiple sequence alignment of proline rich region of RUBV from 7 genotypes. 
Alignment of 14 different genotypes of RUBV reveals high levels of conservation of the 3 
P-x-x-P-x-R sequences (highlighted in green). This alignment was performed by Dr Yumei 
Zhou. 
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Figure 3.3. Viral titers in culture fluid from transfection plates and plaque morphologies.   
Vero cells were mock-transfected or transfected with transcripts from the wild type infectious 
clone (Robo502) or Robo502 derivatives containing proline to alanine mutations in the 
predicted SH3 binding motifs 1, 2 and/or 3 (the construct with mutations in all three motifs 
was designated as MutX).  The transfected cells were observed daily for CPE (the day on 
which CPE was first observed is indicated) and the transfected cell medium (designated as 
“passage 0” or “P0”) was collected on day 3 post-transfection and titered by plaque assay.  
The virus titer in each P0 culture fluid and the highest dilution plate on which plaques were 
observed is shown for visualization of plaque morphology.   
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Figure 3.4. Viral titers in culture fluid from infected plates after passage 1 and plaque   
morphologies.   
Vero cells were infected with P0 culture fluids (see Fig. 3.3) and observed daily for CPE (the 
day on which CPE was first observed is indicated).  The culture medium (designated as 
“passage 1” or “P1”) was collected on day 3 post-infection and titered by plaque assay.  The 
virus titer in each P1 culture fluid and the highest dilution plate on which plaques were 
observed is shown for visualization of plaque morphology.   
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Construct1 
 
Sequence1 
Wild type Robo502 Wild type sequence 
Robo502-MUT1 Reverted to wild type sequence 
Robo502-MUT2 Reverted to wild type sequence 
Robo502-MUT3 No revertants; mutation still at motif 3 
Robo502-Mut1+2 Motif 1 reverted to wild type sequence 
Robo502-MUTX Motif 1 and 2 reverted to wild type sequence; mutation still at 
motif 3 
Table 3.1. Sequence of Robo502 PxxPxR motif mutants after one passage in Vero cells. 
1Vero cells were transfected with the indicated Robo502 constructs.  The transfected culture medium was 
harvested and passaged once in Vero cells.  The PRR domain of passaged virus was sequenced.
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Figure 3.5. P150 and RNA production by Robo502 wt and mutant RNA. 
(A and B). Vero cell were transfected with transcripts from the wild type and mutant Robo502 
–930 infectious cDNA clones which contain an HA epitope-tagged P150. Viral RNA 
transcript from 2 clones of each mutant was used. Lysates of the transfected cells were made 
at 6 hours and 3 days post-transfection.  Proteins in the cells lysates were resolved by 6% 
SDS-PAGE followed by Western blot analysis using mouse monoclonal anti-HA antibody. 
(C) Vero cells transfected with transcripts from wild type and mutant Robo502-930 infectious 
cDNA clones were harvested 3 days post-transfection and total cell RNA was extracted and 
resolved on a 1% agarose gel followed by  Northern blotting probed with VR-C-E2-E1 (see 
Materials and Methods)   
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Figure 3.6. GST-PRR expression vector. 
The P150 PRR was cloned into the pEBG mammalian expression vector between the Bam HI 
and Cla I restriction sites as shown to produce a GST-PRR fusion protein when expressed in 
transfected 293T human embryonic kidney cells.
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 Figure 3.7. Schematic of procedure used to identify proteins interacting with GST-PRR 
fusion protein.   
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Figure 3.8. Resolution of cell proteins interacting with pGST-PRR and pGST-PRR-MUT 1+2 
fusion proteins. 
293-T cells were transfected with the wild type (pGST-PRR/RUB (lane 1) or mutant (pGST-
PRR/RUB-Mut1+2)(lane 2) GST fusion protein expression constructs and lysates were 
prepared 68 hours post-transfection and incubated with gluthathione sepharose 4B beads. 
Bound proteins were eluted and resolved by 10% SDS-PAGE (Panel A) or 6% SDS-PAGE 
(Panel B).  Proteins that bound to the wt fusion protein but not to the mutant fusion protein 
(PRR1-PRR4) were excised and identified by trypsin digestion and mass spectroscopy.   
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Figure 3.9. Interaction of GST-PRR fusion proteins with host cell protein 
p32/HABP1/gC1qR.  
293-T cell lines were transfected with pEBG, wild type GST-PRR/RUB or mutant GST-
PRR/Mut1+2 vector DNA.  Three days post-transfection, the cells were lysed, and the GST or 
GST-PRR proteins and interacting cell proteins were isolated on glutathione sepharose 4B 
and resolved by 10% SDS-PAGE followed by Western blotting probed with polyclonal rabbit 
anti-p32 antibody.  As can be seen, p32 interacted with the wt GST-PRR/RUB fusion protein, 
but not the GST-PRR/Mut1+2 fusion protein or the control GST protein. Additional bands 
below arrow indicating p32 could be degradative products of p32.  
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Figure 3.10. Co-immunoprecipitation of expressed P150 with endogenous p32. 
Vero cells were either mock-transfected (lanes 1 and 2) or transfected with a plasmid vector 
(CMV-P150-HA) expressing an HA epitope-tagged P150 (lanes 3 and 4) and lysed two days 
post-transfection. The lysates were immunoprecipitated with monoclonal mouse anti-HA 
antibody or rabbit anti-P32 antibody followed by 6% SDS-PAGE and Western blot probed 
with anti-HA antibody.  As can be seen, in the CMV-P150-HA-transfected cells, HA-tagged 
P150 was immunoprecipitated by both anti HA (control) and anti p32 antibody.   
 
208 kDa 
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Figure 3.11. Co-immunoprecipitation of expressed p32 and P150 in RUBV-infected cells. 
Vero cells were mock-transfected (lanes 1 and 3) or infected with Robo502-912 (which 
expresses a FLAG-tagged P150) and transfected with HA-p32-c-myc (which expresses p32 
N- and C-terminally tagged with HA and c-myc epitopes, respectively).  Two days post-
infection/transfection cells were lysed and samples were immunoprecipitated using 
monoclonal mouse anti-FLAG or mouse anti-HA antibody followed by 6% SDS-PAGE and 
Western blot probing with monoclonal mouse anti-FLAG antibody.  As can be seen, FLAG-
tagged P150 was immunoprecipitated with both anti-FLAG (control) and anti-HA antibody.  
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Figure 3.12. Reciprocal co-immunoprecipitation of expressed P150 and p32. 
VERO cells were either mock transfected or co-transfected with CMV-P150-HA, which 
expresses an HA-tagged P150, and p32-c-myc, which expresses a C-terminal c-myc tagged 
p32. Two days post-transfection, the cells were lysed and immunoprecipitated with 
monoclonal mouse anti-HA or anti-c-myc antibody.  Following resolution by 6% and 10% 
SDS-PAGE, respectively, Western blot analysis was performed using anti-HA (Panel A) or 
anti-c-myc (Panel B) antibodies.  As can be seen, anti HA and anti-c-myc antibodies both 
immunoprecipiated HA-tagged P150 (Panel A) and, reciprocally, anti c-myc and anti-HA 
antibodies both immunoprecipitated c-myc tagged p32 (Panel B).  Additional band above 
p32-c-myc in lane 4 may represent a modified p32.  
 
208 kDa 
37 kDa 
119 
 
 
 
 
 
 
 
 
 
 
Figure 3.13. Colocalization of endogenous p32 with P150. 
A) Vero cells were infected with Robo502-912, which expresses a FLAG epitope tagged 
P150. Twenty four hours post-infection, the cells were processed for IFA using mouse anti-
FLAG antibody (green) and rabbit anti-p32 antibody (red). B) Vero cells were transfected 
with CMV-P150-HA. Twenty four hours post-infection the cells were processed for IFA 
using mouse anti-HA antibody (red) and rabbit anti-p32 antibody (green). Hoechst Dye was 
used to stain nuclear DNA (blue). The cells were visualized using Zeiss Axioplan 2 
imaging system at 100X magnification. 
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Figure 3.14. Lack of co-immunoprecipitation of p32 with a P150 that has mutated PxxPxR 
motifs. 
Vero cells were mock transfected (lanes 1 and 2), co-transfected with CMV-P150-HA and 
p32-c-myc (lanes 3 and 4) or co-transfected with CMV-P150-HA/Mut1+2 and p32-c-myc 
(lanes 5 and 6). Two days post-transfection, the cells were lysed and the lysates were 
immunoprecipitated using monoclonal mouse anti-HA (lanes 1, 3, and 5) or mouse anti-c-myc 
(lanes 2, 4, and 6) antibody.  The immunoprecipitated proteins were resolved by 6% SDS-
PAGE followed by Western blot analysis probing with anti-HA antibody.  As can be seen, wt 
expressed P150 was co-immunoprecipitated by anti-c-myc antibody while the mutant 
expressed P150 was not.    
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Figure 3.15. Expression of transfected p32-c-myc. 
Vero cells were mock transfected or transfected with p32-c-myc and then infected the 
next day with RUBV, or just transfected with p32-c-myc.  On days 1 through post-
transfection, cells were lysed and the lysates were resolved by 10% SDS-PAGE 
followed by Western blot analysis probed with mouse monoclonal anti-c-myc antibody.   
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Figure 3.16. Intracellular localization of expressed c-myc tagged p32. 
Vero cell lines were mock transfected or transfected with pcDNA-p32-c-myc.  On days 2 and 3 post-
transfection, cells were processed for IFA using anti-c-myc antibody (green). Hoechst Dye was used 
to stain nuclear DNA (blue).  The cells were visualized using a Zeiss Axioplan 2 imaging system 
under 100X magnification.  
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1Vero cells were mock-transfected or transfected with pcDNA-p32-myc and then infected with 
RUBV (MOI = 1 pfu/cell) the next day.  The culture medium was harvested daily and titered by 
plaque assay. This experiment was done twice and the titers are averaged. 
 
Table 3.2. RUBV replication in Vero cells over-expressing p32. 
 
